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1 Summary
1.1 Deutsche Zusammenfassung
Hintergrund In der ju¨ngeren Vergangenheit haben wissenschaftliche Studien gezeigt,
dass es mo¨glich ist, mittels MRT-basierten multivariaten Mustererkennung mit einer ho-
hen Klassifizierungswahrscheinlichkeit zwischen neu erkrankt psychotischen (ROP) und
neu erkrankt depressiven (ROD) Patienten zu unterscheiden [Koutsouleris et al., 2015].
Allerdings werden insbesondere depressive Patienten mit fru¨hem Krankheitsbeginn o¨fter
als ROP missklassifiziert, was zu der Vermutung fu¨hrte, dass eine neuroanatomische A¨hn-
lichkeit zwischen diesen beiden Gruppen bestehen ko¨nnte [Koutsouleris et al., 2015]. Des
Weiteren deuten verschiedene Studien daraufhin, dass sowohl depressive, als auch psycho-
tische Erkrankungsbilder bereits in fru¨hen Stadien spezifische neurokognitive Beeintra¨ch-
tigungsmuster zeigen [Lee et al., 2012, Bora and Murray, 2013]. In diesem Zusammen-
hang ko¨nnte die Anwendung multivariater Musteranalysen an neurokognitiven Daten die
klinische Differentialdiagnostik in Zukunft unterstu¨tzen und erleichtern.
Ziele In dieser Studie wurden univariate und multivariate statistische Analysen durchge-
fu¨hrt um (i) mo¨gliche Leistungsunterschiede in der neuropsychologischen Testbatterie
zwischen ROD- und ROP-Patienten aufzudecken, (ii) Klassifizierungsmodelle mit Hilfe
multivariater Musteranalysen zu erstellen, die anhand krankheitsspezifischer Muster in
den neurokognitiven Daten verla¨sslich zwischen ROD- und ROP-Patienten unterscheiden
ko¨nnen und (iii) diese Klassifizierungsmodelle unter Durchfu¨hrung einer ”Leave-center-
out-Analyse” auf ihre Generalisierbarkeit und externe Validita¨t hin zu pru¨fen.
Methodik Vorla¨ufige Daten von 116 Studienteilnehmer (58 ROD (Alter: 25.5 ± 6.0
Jahre), 34 weiblich; 58 ROP (25.6 ± 5.2 Jahre), 16 weiblich) des PRONIA-Projektes
wurden untersucht (vgl. https://www.pronia.eu/). Die Diagnosen der Studienteilnehmer
wurden mittels dem Structured Clinical Interview for DSM-IV - Axis I (SCID-I) veri-
fiziert. Gruppenbezogene Leistungsfa¨higkeit in der neurokognitiven Untersuchung wurde
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mittels t-Tests an den Ergebnissen von 13 etablierten neurokognitiven Tests (u. A. Rey-
Osterrieth Figure Complex Figure Test, Trail Making Test A and B, Rey Auditory Verbal
Learning Test etc.) verglichen. Das Signifikanzniveau der t-Tests wurde entsprechend der
Bonferroni-Methode korrigiert. Klassifizierungsmodelle wurden an den Daten der mul-
tidoma¨nen, neuropsychologischen Testbatterie mittels Support Vector Machine (SVM)-
basierter multivariater Mustererkennung trainiert. Dies wurde getrennt jeweils mit 23
und 214 neurokognitiven Variablen durchgefu¨hrt. Letztlich wurde die Generalisierbarkeit
der Klassifikationsmodelle mittels einer ”Leave-center-out-Analyse” u¨berpru¨ft.
Ergebnisse ROP-Patienten schnitten verglichen mit Teilnehmern der ROD-Gruppe in
fast allen neuropsychologischen Tests schlechter ab. Statistisch signifikante Leistungsun-
terschiede konnten in 9 von 23 Variablen nachgewiesen werden. Folglich zeigten ROP-
Patienten ausgepra¨gtere Defizite in den kognitiven Bereichen Verarbeitungsgeschwindigkeit,
Aufmerksamkeit, verbales Lernen, exekutive Funktionen und pra¨morbider IQ.
In den multivariaten ROD vs. ROP Analysen wurden kreuzvalidierte Klassifikations-
genauigkeiten von 63.8% in der 23-Variablen-Analyse und 71.6% in der 214-Variablen-
Analyse erreicht. Die durchschnittliche Klassifikationsgenauigkeit in der Leave-center-
out-Analyse betrug 72.4% mit einer Sensitivita¨t und einer Spezifizita¨t von jeweils 72.4%.
Schlussfolgerung ROP-Patienten weisen insgesamt deutlich sta¨rkere kognitive De-
fizite als ROD-Patienten auf. Durch die Anwendung von Machine-Learning-Algorhythmen
auf neurokognitive Daten ist es mo¨glich, Patienten mit ku¨rzlich manifestierten depressiven
und psychotischen Sto¨rungsbildern auf individueller Ebene und mit guter Genauigkeit zu
identifizieren. Die Klassifikationsmodelle gewinnen dabei an Genauigkeit, wenn ihnen
gro¨ßere Datenbanken zur Verfu¨gung gestellt werden. Unsere Ergebnisse weisen weiter
daraufhin, dass die erstellten Klassifizierungsmodelle auch auf Patienten anderer Stu-
dienzentren anwendbar und somit generalisierbar sind. Zusammengefasst ko¨nnte die
Anwendung neurokognitiver Daten und computerisierter Mustererkennungsmethoden die
Differentialdiagnostik im klinischen Alltag in Zukunft weiter verbessern und unterstu¨tzen.
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1.2 English Abstract
Background Recent findings have indicated that it is possible to differentiate between
recent onset psychotic (ROP) and recent onset depressive (ROD) patients, using MRI-
based markers in multivariate pattern classification with high accuracy
[Koutsouleris et al., 2015]. However, especially those depressive patients with early onset
of disease tend to be misclassified as ROP, leading to the assumption of a neuroanatomi-
cal likeness between these patient groups [Koutsouleris et al., 2015]. Furthermore, ev-
idence suggests that major depressive as well as psychotic disorders present specific
profiles of cognitive dysfunction early on in the course of the disease [Lee et al., 2012,
Bora and Murray, 2013]. Therefore, using neurocognitive data in the framework of vali-
dated multivariate pattern classification could potentially facilitate clinical differentiation
of recent onset psychotic (ROP) and recent onset depressive (ROD) patients.
Objective In this study, we conducted univariate and multivariate statistical analy-
ses in order to (i) identify performance differences between ROD and ROP subjects on
the PRONIA Neuropsychological Test Battery, (ii) establish classification models in the
framework of multivariate pattern analysis that reliably differentiate between ROD and
ROP subjects based on patterns in the neurocognitive data and (iii) examine these clas-
sification models in a leave-center-out analysis in order to assess their generalizability.
Methods Preliminary data of 116 subjects (58 ROD (mean age: 25.5 ± 6.0 yr), 34
female; 58 ROP (25.6± 5.2yr), 16 female) from the PRONIA-project was examined (cf.
https://www.pronia.eu/). Subjects’ diagnoses were assessed using the Structured Clini-
cal Interview for DSM-IV - Axis I (SCID-I). Group performances on the neurocognitive
assessment were compared by conducting Bonferroni-adjusted 2-sample t-tests on scores
from 13 well established neurocognitive assessments (e.g. Rey-Osterrieth Figure Com-
plex Figure Test, Trail Making Test A and B, Rey Auditory Verbal Learning Test etc).
Classification models were trained on results from the multi-domain PRONIA Neuropsy-
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chological Test Battery using Support Vector Machine (SVM)-based multivariate pattern
analysis. This was conducted separately for 23 and 214 neurocognitive variables. Lastly,
generalizability was estimated by conducting a leave-center-out multivariate analysis.
Results ROP patients performed relatively poorer than ROD subjects in almost all
tests. Statistically significant performance differences were found in 9 out of 23 variables.
Accordingly, ROP patients presented greater deficits in the cognitive domains speed of
processing, attention, verbal learning, executive functions and premorbid IQ.
For the ROD vs. ROP analysis, cross-validated classification accuracies were 63.8% in the
23 variables analysis and 71.6% in the 214 variables analysis, respectively. The average
classification accuracy in the leave-center-out analysis was 72.4%, with both sensitivity
and specificity of 72.4%.
Conclusions ROP patients generally exhibit far greater cognitive deficits than ROD
patients. By implementing machine learning algorithms trained on neurocognitive data
to differentiate between diagnostic groups, it is possible to reliably identify patients with
depressive and psychotic disorders on an individual level. These classifiers gain diagnostic
accuracy when presented with larger data sets. Our findings further indicate that these
classification models are generalizable to patients from other clinical centers. Hence, pat-
tern recognition methods on neurocognitive data may improve machine based diagnostic
differentiation and therefore enhance clinical diagnostic accuracy in the future.
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2 Introduction
2.1 Depression
2.1.1 Definition and Epidemiology
Major depressive disorder (MDD) is one of the most prevalent mental disorders today,
with patient numbers continuously increasing over the last years. In Germany, the life-
time prevalence of depression lies around 9.9% with women being affected about twice as
often as men [Kessler and Bromet, 2013, Association et al., 2013].
Furthermore, the World Health Organization (WHO) expects MDD to rank second in
leading diseases, measured in disability-adjusted life years, by the year 2020, surmounted
only by heart disease [Chapman and Perry, 2008]. As a consequence, in 2004 the costs
of MDD in Europe was already estimated to mount up to Euro 118 billion and therefore
accounting for a major economic burden [Sobocki et al., 2006].
The typical age-of-onset of depression lies between the age 30 and 40 with an addi-
tional albeit smaller peak of incidence between the ages 50 and 60 [McGorry et al., 2011,
Kessler and Bromet, 2013].
According to the Diagnostic and Statistical Manual of Mental Disorders (DSM5), MDD
is defined as the presence of two main depressive symptoms: depressed mood and anhe-
donia, at least one of which has to be present on most days for at least two consecutive
weeks. In addition to that, MDD is accompanied by numerous symptoms such as loss of
interest, change in eating, appetite or weight, sleep disorders, lethargic or overly active
motor activity, fatigue and suicidal tendencies [Association et al., 2013]. For the exact
diagnostic criteria, see chapter 2.1.3.
2.1.2 Aetiology
The exact cause of depression is still unknown and remains the focus of ongoing sci-
entific investigation. However, it is generally believed that depression, like most other
mood disorders, has a multifactorial aetiology where genetic, neurochemical, hormonal
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and psychological factors have to be equally taken into account [Ehlers et al., 1988,
Sullivan et al., 2000].
Concerning the pathophysiology, different theories addressing the monoaminergic system,
autoimmune mechanisms and the circadian rhythm have been discussed in recent years.
Theories about the monoaminergic circuit indicate a defective signal transmission re-
garding serotonin, dopamine and noradrenaline [Hamon and Blier, 2013], whereas other
research gives reason to believe that immune system abnormalities have a propulsive
effect in causing depressive symptoms [Ko¨hler et al., 2014].
2.1.3 Diagnostic Criteria
In order to diagnose a patient with MDD, certain diagnostic criteria have to be fulfilled.
Depending on the respective state or country, these criteria are defined by the Statistical
Manual of Mental Disorders (DSM5) or the International Statistical Classification of
Diseases and Related Health Problems (ICD-10) developed by the WHO. Below, I will
only contemplate the criteria as described in the DSM-5 since diagnostic classification in
this study was performed using the Structured Clinical Interview for DSM-5 (SCID).
Firstly, 5 or more of 9 symptoms have had to be present throughout two consecutive
weeks. Furthermore, in order to fulfill the criteria at least one of the first two symptoms
had to be present:
1) depressed mood
2) loss of interest or pleasure
3) significant weight loss or gain
4) insomnia or hypersomnia
5) psychomotor agitation or retardation
6) fatigue or loss of energy
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7) feelings or worthlessness or guilt
8) loss of concentration and indecisiveness
9) recurrent thoughts of death or suicidal tendencies/attempts
Secondly, symptoms have to be severe enough to cause significant distress or impairment
in social, occupational or other areas of functioning, while the depressive episode is not
attributable to the effects of a substance or another medical condition.
Lastly, it has to be excluded that the depressive episode is not better explained by any
mental disorder of the psychotic spectrum nor did a manic or hypomanic episode ever
occur in the patient history [Association et al., 2013].
2.1.4 Therapy and Prognosis
The management and treatment of major depressive disorder consists of diverse therapeu-
tic approaches such as antidepressant medication, psychotherapy, lifestyle adjustments,
electroconvulsive therapy, transcranial magnetic stimulation and others. The specifics of
the treatment may differ between individuals based on the severity, number of episodes
or other peculiarities of the depressive episode.
Although about 50% of major depressive episodes resolve by themselves, whether they
are treated or not, reoccurrence is much more likely when inappropriate or no treatment
has been administered [Eaton et al., 2008, Geddes et al., 2003]. In general, about 80%
of patients with a major depressive episode will experience at least one more episode in
their lifetime [Fava et al., 2003].
Furthermore, people affected by MDD statistically exhibit a reduced life expectancy
[Cassano and Fava, 2002]. This is for one due to the elevated number of suicides among
this cohort, but also conditioned by an increased likelihood for an unhealthy conduct of
life resulting in higher risk for heart disease and other medical conditions
[Leung et al., 2012, Alboni et al., 2008].
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2.2 Psychosis
2.2.1 Definition and Epidemiology
Psychosis - or rather the psychotic episode - is generally understood as a temporary or
permanent state of mind in which the affected person suffers from a detachment of reality.
Thus, the patient may experience a diverse spectrum of symptoms including hallucina-
tions, delusions, thought disorder, aberrant salience and catatonia. Psychosis however is
not a psychiatric diagnosis by itself, rather than a condition that may occur in the context
of a multitude of psychiatric entities such as schizophrenia, schizophreniform disorders,
schizoaffective disorder, delusional disorder, or mood disorders like bipolar disorder and
Major Depressive Disorder [Cardinal and Bullmore, 2011].
Likewise, psychotic episodes can be caused or induced by a vast variety of substances
and medical conditions, making it essential in the diagnostic process to exclude any pos-
sible external causes before confirming a definite psychiatric diagnosis [Cummings, 1985,
Cardinal and Bullmore, 2011].
Due to this polymorphism of psychosis, exact numbers for incidence and prevalence re-
main somewhat unclear. Targeting all forms of psychotic disorders, a study from 2007
conducted by researchers of the University of Helsinki described the all-over lifetime preva-
lence as 3.06%, in a general population [Pera¨la¨ et al., 2007]. Thereof, Pera¨la¨ et al. further
state, the majority was made up by patients with schizophrenia, accounting for a preva-
lence of 0.87%. Accordingly, the prevalence of schizophrenia alone is generally estimated
to lie between 0.3 and 0.8% in an average western population [McGrath et al., 2008].
For example, a systematic review of 2012 marked a pooled annual incidence of 32 cases per
100.000 people for psychotic disorders in general and 15 per 100.000 people for schizophre-
nia in specific [Kirkbride et al., 2012]. The average age-of-onset for psychotic disorders
lies between 20 and 35 years, with a slightly later onset of episodes that have an underly-
ing affective disorders. Moreover, it is a well-established fact that the average age-of-onset
in women is approximately 5 years later than in men [Loranger, 1984].
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2.2.2 Aetiology
Analog to MDD and most other mental health disorders, the exact causes of psychosis
remain elusive. However, since the first medical reports of psychosis in the 20th century,
numerous factors causing or contributing to the outbreak of psychosis have been identi-
fied and hypothesized.
On a neurochemical level, undoubtedly the most common theory is the dopamine hy-
pothesis of schizophrenia and psychosis. This hypothesis attributes psychotic symptoms
to a dysbalance of dopaminergic signal transductions, especially in the mesolimbic path-
way [Kapur et al., 2005]. Originally, this theory arose due to the observation that drugs
blocking D2 dopamine receptors in the brain seem to reduce psychotic symptoms, whereas
drugs and substances leading to a higher dopamine output or concentration have shown
to potentially induce or aggravate psychotic symptoms.
As to how these transmitter dysbalances are triggered remains unclear, with evidence
suggesting hereditary, neurodegenerative, drug and stress related as well as social and
environmental factors [Drake et al., 2000, Broome et al., 2005].
2.2.3 Diagnosis
When confronted with a patient that presents psychotic symptoms, such as delusions,
hallucinations or any other form of bizarre thought disorder, it is of foremost impor-
tance to rule out any potential organic or drug related cause of the psychotic episode
[Griswold et al., 2015]. To do so, health care professionals avail themselves with medical
histories, brain scans, cerebrospinal fluid diagnostics, blood tests, neurological examina-
tions and a multitude of further diagnostic instruments.
Only if the subsequent results are negative, can the physician rule out a secondary cause
of the psychotic episode and proceed to examine the exact nature of the primary psy-
chotic disorder at hand. Here, the intensity, frequency and duration of the respective
symptoms, as well as the knowledge about any prior episodes of psychotic or affective
disorders are decisive for the exact psychiatric diagnosis [Association et al., 2013].
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2.2.4 Therapy and Prognosis
In order to treat acute psychotic episodes, healthcare professionals nowadays primarily
rely on the use of antipsychotics [Stahl and Mignon, 2010]. Antipsychotics, traditionally
divided into typical and atypical subtypes, are drugs targeting a range of dopamine
receptors, but also histamine and serotonine receptors in the brain and have shown to
effectively reduce psychotic symptoms in patients with primary psychosis.
However, in modern psychiatry, psychotherapeutic programs and occupational therapy
play a substantial role in the treatment of psychotic disorders [Moritz et al., 2011]. By
implementing psychotherapeutic, psychoeducational and psychosocial programs into the
treatment, psychiatrists hope to achieve a better rehabilitation of people suffering from
psychosis and therefore a higher outcome of compliance and remission in the long term
[Segarra et al., 2012].
The prognosis for patients suffering from a psychotic episode is greatly dependent on the
cause of the initial outbreak. While secondary psychoses often have a good prognosis
when the underlying disorder is treated, the outcome of primary psychoses tends to vary
from patient to patient. According to a systematic review on longitudinal outcome studies
of first episode psychoses, about 42% of cases with first episode psychosis (FEP) will see
a good outcome. 35% of the affected people will have an intermediate outcome with
some remaining symptoms or impairments and about 27% of the patients will experience
a poor outcome with a chronic progression of the disease [Menezes et al., 2006].
Additionally, according to Laursen et al., patients with schizophrenia have a reduced
life expectancy of 10 to 25 years, due to unhealthy lifestyles, the side effects of the
antipsychotic treatment and an increased risk of committing suicide [Laursen et al., 2012].
2.3 Neuropsychology in Psychiatry
The scientific discipline of neuropsychology studies the processes and function of the
brain in its diverse domains such as memory, intelligence, verbal and motoric function-
13
ality and many more. In that, neuropsychology links findings from the disciplines neu-
rology, psychology, cognitive neuroscience and, with regards to artificial neural networks,
even computer science. To do so, neuropsychologists utilize neuroimaging methods like
magnetic resonance imaging (MRI), clinical neuropsychological assessments, electrophys-
iological monitoring of the brain like electroencephalography (EEG) and numerous other
methods, to obtain a deeper understanding of the specific brain mechanisms leading to
cognitive processes and behavioral patterns.
In psychiatry, clinical neuropsychology plays an increasingly important role by conduct-
ing comprehensive assessments with individual patients and therefore gathering valuable
information contributing to an accurate diagnostic classification [Keefe, 1995].
Furthermore, neuropsychological assessments have become a popular instrument in psy-
chiatric research for the quantification of therapeutic effects of new medications or psy-
chotherapeutic treatments. On an individual level, results from neurocognitive assess-
ments enable tailored cognitive training plans for patients suffering from cognitive deficits
and thus enhancing disease remission and occupational rehabilitation [Keefe, 1995].
2.3.1 Neuropsychology and Depression
For many years, psychologists and psychiatrists accepted cognitive impairment in depres-
sive patients as a mere side effect of depressed mood or understood poor performance in
neuropsychological assessments as a result of lacking motivation and inattention. How-
ever, a meta-analysis of 2001, performed by Austin et. al, suggested a disease specific pat-
tern of cognitive impairments in depressive patients. Interestingly, this pattern -mainly
including deficits in episodic memory, learning, executive functions and attentional set-
shifting- is not necessarily depending on the severity of the illness, nor on the age of the
study participants [Austin et al., 2001]. Hence, Austin et. al concluded that impairment
in memory and executive functioning are not simply attendant circumstances in depres-
sive disorders, rather than a core feature of this diagnostic category [Austin et al., 2001].
Another study review, published by McIntyre et al. in 2013, confirmed cognitive deficits
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in depression to mainly present in the domains executive functions, working memory,
attention and processing speed [McIntyre et al., 2013].
In 2012, researchers around Rico S.C. Lee from the Macquarie University, NSW, Aus-
tralia, conducted a meta-analysis exclusively focusing on cognitive deficits in patients
with first episode MDD. Here, significant results were found for cognitive impairment in
the domains psychomotor speed, attention, memory and executive functioning even in an
early stage of the disease [Lee et al., 2012]. Furthermore, Lee and colleagues could not
find any links between cognitive deficits and illness severity, indicating once again that
the specific cognitive deficits may be a defining feature of MDD [Lee et al., 2012].
2.3.2 Neuropsychology and Psychosis
Neuropsychological findings concerning cognitive impairment in psychosis have been well
described and extensively studied. Heinz and Zakzanis published a meta-analysis in
1998, indicating vast cognitive impairment in patients with schizophrenia compared to
healthy controls, with an emphasis on the domains verbal memory, intelligence quotient
(IQ), attention and verbal fluency [Heinrichs and Zakzanis, 1998]. A metaanalyis of 2009,
conducted by Mesholam-Gately et al. confirmed these results and, while strictly focusing
on first episode schizophrenia, found impairments to be maximal in verbal memory and
processing speed [Mesholam-Gately et al., 2009].
Further research suggests that similar patterns of impairment can be found in other
diagnostic groups of the psychosis spectrum, such as schizoaffective disorder or affective
disorders with psychotic symptoms, albeit patients with schizophrenia still present greater
measurable impairment in comparison [Reichenberg et al., 2008].
Nevertheless, cognitive deficits in the domains memory, executive functions, attention
and processing speed seem to be a conjunctive pattern when examining different forms of
psychosis [Reichenberg et al., 2008]. In addition, a 5 year follow-up study examining the
neurocognitive development in first episode psychosis found the course of neurocognition
to be more dependent on the number of recurring episodes than the exact diagnosis
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[Barder et al., 2013].
It is also being discussed whether the described cognitive deficits may not simply be
an epiphenomenon of full-blown psychosis rather than a reliable trait of the illness that
often presents even before the prodromal stage of a psychotic episode becomes clinically
apparent [Bora and Murray, 2013]. Hence, a number of researchers in psychiatry have
suggested to include cognitive deficits into the diagnostic criteria of psychosis, especially
since these deficits are objectively measureable as opposed to delusions or hallucinations
[Lewis, 2004, Tsuang and Faraone, 2002].
2.4 Differential Diagnosis in Psychiatry
According to the handbook of the DSM-5, differential diagnosis in psychiatry happens in a
number of subsequent steps [First, 2013]. Hence, as a first measure when confronted with
a patient in psychiatry, it is elementary to rule out Malingering and Factitious Disorder.
Secondly and thirdly, the clinician is expected to dismiss drugs and medications as well
as any medical conditions as the aetiology of the symptomatology at hand. Only now can
the psychiatric clinician begin to examine the exact nature of his or her patient’s disorder
by following a diagnostic tree that leads from symptom to syndrome to a final diagnosis.
To do so, the clinician may make use of a vast number of diagnostic instruments such as
the SCID-I and -II or psychometric scales like the Beck Depression Inventory - II (BDI)
or the Positive and Negative Syndrome Scale (PANSS).
However, the process and therefore diagnostic accuracy depend on a multitude of diverse
factors including the clinician’s experience, the physician-patient relationship and the
patient’s ability to articulate his symptoms. Furthermore, in contrast to most other
medical disciplines, physicians in the psychiatric field have few to no additional tools to
verify or falsify a diagnosis, other than i.e. neurocognitive assessments and EEG. As
a result, diagnosis in psychiatry is a fragile construct oftentimes susceptible to errors
[Freedman et al., 2013].
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2.5 Multivariate Analysis and Machine Learning Algorithms
Generally speaking, multivariate analysis techniques differ from univariate statistics by
taking multiple variables into account when carrying out statistical calculations.
In the framework of supervised learning and computer based classification methods, ma-
chine learning algorithms that aim to recognize specific and generalizable patterns in the
examined multivariate data have become increasingly popular in modern psychiatric re-
search [Koutsouleris et al., 2014]. In this work’s context, supervised learning means that
I provide my classification algorithm (e.g. support vector machine) with the subject’s
label, i.e. diagnosis, when instructing it to establish classification models based on label-
specific patterns in the data. Hereby, the classifier knows in which subgroups of the study
subjects it has to search for patterns in the data presented to it.
In a nutshell, pattern recognition algorithms aim to identify label-specific patterns in com-
prehensive datasets, may it be voxel-based MR Imaging data, neurocognitive assessment
results or even demographic variables, in order to facilitate inter-label classification.
2.5.1 Support Vector Machine (SVM)
SVMs are a kind of mathematical machine learning classification algorithm that function
in a supervised machine learning environment by identifying patterns or differences in
before defined samples (e.g. study groups). Subsequently, an SVM can use this acquired
knowledge in order to classify new and unseen data instances to one of the known groups
[Koutsouleris et al., 2009, Burges, 1998].
From a more technical prospective, the SVM operates as follows: In order to identify said
label-specific patterns, each subject is projected in a hyperdimensional space, with the
dimensionality corresponding to the number of variables the SVM is presented with. It is
now the SVMs’ task to create a separating hyperplane (SH) between the two label groups
the classifier trains on. To do so, the SVM avails itself with so-called support vectors.
These are vectors that indicate the minimal distance between the nearest data entries
of the two opposite label groups and the separating hyperplane. In a linearly separable
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training data set there are usually many competing hyperplanes. Therefore, in order to
identify the optimal separating hyperplane (OSH), the SVM chooses the hyperplane with
the longest support vectors. In other words: the best hyperplane is the one that always
maintains the maximum distance to all data points of the two separable training groups
[Mueller et al., 2015].
SV
SV
SV
SV
OSH
A B
Figure 1: Schematic representation of the identification of the OSH. A, a vast
number of hyperplanes separating the two training groups can be found. In B, the SVM
identified the OSH by maximizing the distance between the nearest training subjects
(black dots) of each training group and the OSH. SV: support vector; OSH: optimal
separating hyperplane.
It is important to keep in mind that the OSH is a linear mathematical construct that can
only function in a linear environment, whereas in reality almost all training data sets are
nonlinear. Hence, in order to create such a linear environment, it is possible to transform
the training data set into a high-dimensional feature map where linear separation becomes
mathematically feasible. In reality however, this procedure would require huge amounts
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of computational power. Therefore, it is more convenient to apply a so-called kernel trick.
The kernel trick exploits the mathematical nature of the separation problem and makes
non-linear seperation possible without projection to higher space. The most common
kernel is the radial basis function kernel [Koutsouleris et al., 2009].
A B
Figure 2: Schematic representation of the transformation to high-dimensional
feature map. A, the space in non-linear and therefore not separable by a linear OSH.
In B, by applying the radial basis functions kernel the data entries are transformed into
a high-dimensional feature map, enabling the linear OSH to separate the two training
groups. Note that this is only a theoretical representation since the kernel trick avoids
actual projection to a higher-dimensional space. Blue dots: training group 1; red dots:
training group 2; black dots: nearest subjects to OSH; yellow plane: OSH.
Lastly, since it may not always be possible to find a linear OSH that reliably separates all
data entries of the two opposite data groups and also to mitigate the risk of overfitting,
it is possible to determine so-called slack variables. These allow the SVM to knowingly
misclassify data instances that lie within a certain margin around the OSH.
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2.5.2 Cross-validation (CV)
When trying to establish a new diagnostic instrument, e.g. a self-rating questionnaire to
measure the severity of a symptom or -as in this work- a classification model, it is always
of primary interest to test this instrument for its accuracy, sensitivity and specificity in
order to validate its performance. One way to do so is by performing a cross-validation.
Here, the data is randomly divided into κ folds. Each fold has approximately the same
size and composition. Now, the cross validation will perform κ validation runs with κ−1
folds serving as the training data and the remaining fold serving as test data. Hence,
each one of the κ folds will serve as test data exactly once. Now, using the κ − 1 folds
as training data, the instrument -in this work the SVM- will generate a prediction model
that is then applied to the test data in order to predict the properties of interest (in
this work the group membership). Since these properties are known in beforehand, the
accuracy of each of the κ models generated can be calculated. Finally, the parameters
accuracy, sensitivity and specificity of the κ runs are averaged out and thus indicate the
overall performance of the instrument or classifier at hand [Kohavi et al., 1995].
data pool
divided into  folds
Test
Test
Test
Test
Test
Training
Training
Training
Training
Fold 1
Fold 2
Fold 3
Fold 4
Fold 5
Figure 3: κ-fold cross-validation in principle.
For each fold accuracy, sensitivity and specificity of the model are calculated.
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Repeated Double Cross-Validation (rdCV) CV is a suitable technique when aim-
ing to estimate a prediction model’s performance. However, with small sample sizes,
simple κ-fold cross-validation is running the risk of eliding a possible overfitting effect
[Faber, 2007]. In previous research, repeated double cross-validation has been proposed
to be an eligible solution for this problem [Filzmoser et al., 2009].
Principally, rdCV functions the same way as CV with the only difference that it has an
inner (CV1) and outer (CV2) loop. While the outer CV2 loop is comparable to the κ-fold
cross-validation, the CV1 is a loop with again κ permutations generated from the data
of each fold of the outer loop. This way, in the inner loop the generated models can
tune its parameters for maximum performance and then test these models on the outer
loop. By that, the number of tests is increased and therefore prediction performance and
variability can be better estimated [Filzmoser et al., 2009].
outer loop
inner loop
tune parameters
for optimal models
on inner loop
select optimal parameters
and apply to models 
validated on outer loop
Figure 4: Scheme of repeated double cross-validation. Cross-validation is per-
formed on the inner loop (= CV1). Best parameter and variable set-ups are applied to
models validated on the outer loop (= CV2). Therefore ’double cross-validation’.
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2.5.3 Pattern Recognition Analyses in Psychiatric Research
In recent years, machine learning algorithms have been increasingly implemented in the
framework of psychiatric research, with scientists hoping to establish new classification
models that will enhance diagnostic accuracy in psychiatry and that may even support
clinicians in their therapeutic decision making.
Originally, in the early years of this millennium the application of machine learning al-
gorithms to functional MRI data shaped the term multivariate pattern analysis (MVPA)
[Haxby, 2012].
As a result, in the following years these methods have been frequently applied to MR
Imaging data with the aim of revealing brain-morphologic, disease-specific patterns that
remain elusive to mere visual inspection. For instance, in 2005, Davatzikos et al. used
SVM algorithms on MRI data to differentiate between patients with schizophrenia and
healthy controls, reaching an overall accuracy of 81.1% and thus providing additional
evidence for the usefulness of MVPA [Davatzikos et al., 2005]. In a similar study of 2007
that performed a partial least squares analysis instead of operating an SVM, Kawasaki
and colleagues reached an accuracy of 90% when classifying schizophrenic patients vs.
healthy controls based on their brain MR images [Kawasaki et al., 2007].
In a meta-analysis of 2015, Kambeitz et al. assessed a total of 38 studies that imple-
mented multivariate pattern recognition methods on brain scans in order to differentiate
schizophrenic patients from healthy controls. As a result of their research, they found
that differentiation based on functional and structural brain alterations was achieved
with an overall sensitivity of 80.3% and a specificity of 80.3%, with studies focusing on
resting state functional MRI reaching higher classification results than studies focusing
on structural MRI data (sensitivity/specificity: 84.46%/76.9% and 76.4%/79.0%, respec-
tively) [Kambeitz et al., 2015].
However, as a second metaanalysis of 2016 suggests, these patterns of brain alterations
are not limited to psychotic disorders. Instead, when examining 33 studies that applied
MVPA to magnetic resonance imaging in order to differentiate between healthy controls
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and patients with major depressive disorder, classification results were almost equally as
effective (sensitivity: 77% and specificity: 78%) [Kambeitz et al., 2016].
Further, a study of 2008 by Christos Davatzikos and his team of the University of Penn-
sylvania presented evidence that MVPA can detect patterns of brain alterations in pro-
dromal Alzheimer’s disease and therefore even before the breakout of the apparent illness
[Davatzikos et al., 2008].
Based on these findings, the question has been raised whether multivariate pattern recog-
nition may not only facilitate the differentiation of diseased vs. healthy subjects, but also
present a serviceable instrument in differential diagnosis of diverse psychiatric disorders.
Accordingly, a study of 2015 by Koutsouleris et al. conducted multivariate pattern anal-
ysis on structural MRI data in order to separate patients with schizophrenia and patients
with MDD. As a result, the classifiers reached a balanced classification accuracy of 76%,
with 79.8% of the schizophrenic and 72.2% of the depressive patients being correctly as-
signed to their respective cohort [Koutsouleris et al., 2015]. To test for generalizability,
Koutsouleris et al. also applied the beforehand generated pattern recognition models to
an independent patient cohort of 35 patients with bipolar disorder, 23 patients with first
episode psychosis and 89 subjects with clinically defined at-risk mental states for psy-
chosis (ARMS). Here, 74% of the bipolar patients were assigned to the MDD group, while
83% of the FEP patients and an average of 69% of the ARMS group were labelled as
schizophrenic [Koutsouleris et al., 2015]. As a consequence to these results, Koutsouleris
et al. conclude that neuroimaging pattern recognition may be a practical and valid in-
strument for differential diagnosis in psychiatry [Koutsouleris et al., 2015].
Furthermore, it has been discussed whether MVPA might also facilitate the early de-
tection of mental disorders, as it may detect brain-morphologic alterations long before
the outbreak of a psychiatric illness. Prior research has already shown promising results,
with neuroanatomical biomarkers helping to identify ARMS subjects and their respec-
tive clinical outcome and therefore offering a reliable tool for early detection of psychosis
[Koutsouleris et al., 2009].
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In addition to that, evidence suggests that early detection and disease prediction is also
feasible when focusing solely on disease-specific neurocognitive patterns, giving reason to
believe that multi-modal pattern recognition methods may enhance diagnostic classifi-
cation accuracy as well as early disease detection and outcome prediction in the future
[Koutsouleris et al., 2011].
2.6 Aims of this Study
In this study, I performed both, univariate and multivariate statistics on neurocognitive
data of patients with recent onset depression (ROD) and recent onset psychosis (ROP).
The aims of the study were as follows:
i) identifying differences in the performance on the neurocognitive test battery be-
tween ROD and ROP subjects, by performing univariate statistical analysis,
ii) generating classification models based on neurocognitive pattern analysis that dif-
ferentiate reliably between ROD vs. ROP patients and
iii) applying classification models that differentiate between ROD and ROP subjects
to an independent study sample from an outside study center in order to test for
generalizability (leave-center-out analysis).
In addition, I intend to compare the performance of multivariate classifiers that have
been trained with variables reported in previous literature, with classifiers that have
been provided with a larger set of variables of the neuropsychological test battery.
Lastly, I aim to compare those variables in our models that were most decisive for the
assignment to a study group with those variables that indicate a cognitive deficit generally
associated with the respective mental disorder. Hence, tackling the question whether our
machine learning algorithms identify the same patterns of cognitive deficits that have
been well established based on the findings of prior research relying solely on univariate
statistics.
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3 Materials and Methods
3.1 The PRONIA Study
All data analyzed in this study has been drawn from a preliminary PRONIA data set
of 2015. The PRONIA Study (Personalised Prognostic Tools for Early Psychosis Man-
agement) is a European research project, under the coordination of Prof. Dr. Nikolaos
Koutsouleris (https://www.pronia.eu/), with study centers at the Ludwig-Maximilians-
University Munich (LMU), the University of Cologne (UKK), the University of Basel
(UBS, Switzerland), the University of Birmingham (Uni BHAM, Great Britain), the
University of Udine (Uni Udine, Italy), the University of Turku (Finland), the University
of Milan (MilanNig, Italy) and the University of Melbourne (Australia). Additionally,
the PRONIA consortium consists of four partners from industry and commerce (resp.
Dynamic Evolution, General Electric Global Research, General Electric Healthcare and
GABO:mi Gesellschaft fu¨r Ablauforganisation :milliarium).
The main goal of the PRONIA Study is to generate a software-based prognostic system
that facilitates differential diagnosis as well as early risk prediction of different psychi-
atric disorders, using brain imaging and complementary data. In order to achieve this
objective the PRONIA Study aims to recruit a total of 1700 participants. Each study
subject is undergoing an extensive examination in which a variety of demographic, bio-
metric and psychometric data is collected. After baseline examination, eligible study
participants are separated into the study groups (i) Healthy Controls (HC), (ii) Recent
onset Depression (ROD), (iii) Recent onset Psychosis (ROP) and (iiii) Clinical High Risk
for Psychosis (CHR). For a detailed list of the psychometric and demographic instru-
ments implemented at study baseline, see Table 1. Furthermore, all study participants
receive between six and seven follow-up examinations, depending on the respective study
group (Table 2). The PRONIA Study has been awarded a 6.000.000e grant by the Euro-
pean Union within the 7th Framework Programme and runs from October 1st 2013 until
October 2018. Grant agreement n°602152.
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Observer rating instruments
1. Structured Interview for Prodromal Syndromes (P Items)
2. Schizophrenia Proneness Instrument - Adult Version
3. Comprehensive Assessment of At Risk Mental State
4. Global Assessment of Functioning
5. Structured Clinical Interview for DSM IV - 1 (Screening + Interview)
6. Demographic and Biographic Data
7. Premorbid Adjustment Scale
8. Positive and Negative Symptom Scale
9. Scale for the Assessment of Negative Symptoms
10. Functional Remission in General Schizophrenia
11. Global Functioning Scales (Social and Role)
12. Chart of Life Events
Self rating instruments
1. WHO Quality Of Life - Short Version
2. Multidimensional Scale of Perceived Social Support
3. Resilience Scale for Adults
4. Coping Inventory for Stressful Situations
5. Social Phobia Inventory
6. Beck Depression Inventory - II
7. Edinburgh Handedness Inventory - Short Version
8. Level of Expressed Emotion Scale
9. Wisconsin Schizotypy Scales - Short Form
10. The Everyday Discrimination Scale
11. Bullying Scale
12. Childhood Trauma Questionnaire
13. NEO Five-Factor Inventory
Neuropsychological instruments
1. Rey-Osterrieth Complex Figure Test
2. Diagnostic Analysis of Nonverbal Accuracy - 2nd Version
3. Forward and Backward Digit Span
4. Semantic and Phonemic Verbal Fluency Test
5. Rey Auditory Verbal Learning Test
6. Trail Making Test A + B
7. Continuous Performance Test - Identical Pairs
8. Self-Ordered Pointing Test
9. Digit Symbol Substitution Test
10. Wechsler Adult Intelligence Scale, Vocabulary + Matrices
11. Salience Attribution Test
Table 1: Data acquisition instruments as used in the PRONIA Study baseline
assessment (T0).
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Examination HC ROD ROP CHR
T0 - Baseline testing X X X X
IV3 - 3 months follow-up interview - X X X
IV6 - 6 months follow-up interview - X X X
T1 - 9 months follow-up testing X X X X
IV12 - 12 months follow-up interview - X X X
IV15 - 15 months follow-up interview - X X X
T2 - 18 months follow-up testing - X X X
Table 2: Follow-up examinations and respective study groups. Neuropsycholog-
ical testing and MRI brain scans are only conducted at baseline, after 9 and 18 months
(that is T0, T1 and T2).
3.2 Subjects
3.2.1 Study population
In the present study, I analyze baseline-data of 116 subjects drawn from a preliminary
PRONIA dataset of 2015, originally consisting of 401 study subjects from the seven re-
cruiting centers LMU (92 subjects), UKK (98 subjects), UBS (70 subjects), Uni BHAM
(33 subjects), Uni Udine (51 subjects), MilanNig (15 subjects) and Turku (42 subjects).
All data of said preliminary dataset has been collected between January 2014 and June
2015.
Of the 116 participants included in this study, 58 presented with recent onset psychosis
(ROP) and 58 with recent onset depression (ROD). Subjects were recruited and tested
at LMU, UBS, UKK, Uni BHAM and Uni Udine (Table 3).
Subjects recruited at the University of Turku were not included in this study, due to an
incongruent Finnish version of the neuropsychological test protocol. Furthermore, none
of the 15 subjects of the recruitment center MilanNig were included in this study, since
no neuropsychological data was available from this center, at the time of data analysis.
Another three subjects were missing more than 25% of data due to technical errors and
were thereupon excluded prior to analysis (Table 4).
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Study group LMU UBS UKK Uni
BHAM
Uni
Udine
TOTAL
ROD (n) 23 9 11 3 12 58
ROP (n) 18 13 17 5 5 58
TOTAL (n) 41 22 28 8 17 116
Table 3: Distribution of subjects across centers. Distribution of the 116 subjects
drawn from the preliminary PRONIA dataset of 2015.
Subject study center study group missing data (%)
#1 LMU ROP 100.0
#2 UBS ROP 95.8
#3 UBS ROP 52.3
Table 4: Subjects excluded due to missing data. Information about the respective
study centers, study groups and percentage of missing data.
3.2.2 Inclusion and Exclusion Criteria
Inclusion criteria In order to be considered as eligible for study inclusion, subjects
had to be between 15 and 40 years old, needed sufficient language skills and had to be
in possession of sufficient capacity to consent. Subjects under the age of 18 additionally
had to produce the consent of their parents or legal guardians.
Subjects assigned to the ROD group had to fulfill the criteria for a Major Depressive
Episode according to the DSM-IV-TR within the last three months prior to study inclu-
sion (DSM-IV-TR, American Psychiatric Association, 2000). In addition, the duration
of the first depressive episode had to be under 24 months, with the study screening visit
as reference date.
For inclusion into the ROP group, subjects had to fulfill the criteria for DSM-IV-TR
affective or non-affective Psychotic Episode within the past three months prior to the
study screening visit. Altogether, the onset of the psychotic episode had to be within the
past 24 months, again with the study screening visit as reference date.
28
Exclusion criteria Subjects were not considered for study inclusion if they fulfilled
one or more of the following criteria:
i) Intelligence Quotient (IQ) below 70
ii) insufficient hearing for neuropsychological testing
iii) current or past head trauma with a loss of consciousness for more than 5 minutes
iv) current or past known neurological disorder of the brain
v) current or past known somatic disorder potentially affecting the structure or func-
tioning of the brain
vi) current or past alcohol dependency
vii) current polytoxicomania or polytoxicomania (according to SCID-I) within the past
six months
viii) infeasibility of MRI scanning due to medical reasons
A detailed list of all somatic disorders potentially affecting the structure or functioning
of the brain that subsequently lead to study exclusion can be found in the appendix.
In addition to the general criteria of exclusion, potential ROD subjects were not con-
sidered for study inclusion if they (i) had had more than one Major Depressive Episode
in their life time, (ii) had taken antipsychotic medication for more than 30 cumulative
days in their life time or within three months prior to the study screening visit at or
above minimum dosage of the ’1st episode psychosis’ recommendations of the DGPPN
(Deutsche Gesellschaft fu¨r Psychiatrie und Psychotherapie, Psychosomatik und Nerven-
heilkunde) S3 Guidelines.
Subjects assigned to the ROP group were not included if they had taken any antipsy-
chotics for more than 90 cumulative days within the last 24 months with a daily dose at
or above minimum dosage according to the ’1st episode psychosis’ recommendations of
the DGPPN S3 Guidelines.
29
3.2.3 Demographic Data
Subjects included in this study were both inpatients as well as outpatients. Of the 116
subjects examined in this study, 43% were female. The mean age of the total sample
was 25.5 ±5.6 with no significant age difference across study groups. A more detailed
listing of the demographic and descriptive variables of the study population at hand can
be found in Table 5.
Demographic and
descriptive variables
ROD ROP TOTAL P
n 58 58 116
Sex (female) [n] 34 16 50
Sex (male) [n] 24 42 66
Mean age [yrs] (SD) 25.5 (6.0) 25.6 (5.2) 25.5 (5.6) ns
Mean BDI (SD) 25.7 (13.1) 24.6 (12.3) 25.2 (12.6) ns
Mean PANSS total (SD) 46.2 (9.9) 74.4 (19.5) 60.3 (20.9) < 0.001
Mean PANSS positive (SD) 7.69 (2.2) 19.5 (6.0) 13.6 (7.3) < 0.001
Mean PANSS negative (SD) 12.2 (4.2) 17.2 (7.3) 14.7 (6.5) < 0.001
Mean PANSS general (SD) 26.5 (6.2) 37.7 (10.0) 32.1 (10.0) < 0.001
Mean GAF-S (SD) 55.0 (12.8) 40.5 (13.3) 47.7 (14.9) < 0.001
Mean GAF-DI (SD) 54.4 (14.6) 44.3 (12.8) 49.3 (14.5) < 0.001
Mean WAIS-A 11.0 (2.3) 8.99 (2.6) 10.0 (2.7) < 0.001
Table 5: Demographic and descriptive measures. Descriptive analyses were per-
formed with t-tests. BDI: Beck Depression Inventory - II, PANSS: Positive and Negative
Syndrome Scale, GAF: Global Assessment of Functioning, WAIS-A: Wechsler Adult In-
telligence Scale - Average.
3.3 Psychometric Instruments
Beck Depression Inventory - II First presented by Beck et al. in 1961, the Beck
Depression Inventory (BDI) is a self-report rating instrument measuring the severity of
depressive attitudes and symptoms of depression [Beck et al., 1961]. In this study, we
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utilize the revised second version of the BDI, as published by Beck and colleagues in 1996
[Beck et al., 1996]. The inventory contains 21 multiple-choice questions covering diverse
symptoms of depression. Scores from 0 to 3 are assigned to the answer options of each
item, thus resulting in possible sum scores of 0 to 63 points. Evaluation is as follows:
scores above 29 indicate severe depression, scores between 20 and 28 indicate moderate
depression, scores from 14 to 19 point towards mild depression and scores between 9 and
13 suggest minimal depression or depressive symptoms. Scores below 8 classify as no
depression [Ko¨llner and Schauenburg, 2012].
The BDI takes approximately 10 minutes for completion and requires basic reading abil-
ities. When completing the BDI-II, subjects should only answer based on their state of
health during the last two weeks.
Positive and Negative Syndrome Scale Divided into the three scales positive, neg-
ative and general psychopathology, the Positive and Negative Syndrome Scale (PANSS)
is an interviewer-rated instrument, designed to quantify different symptom classes in
schizophrenia. It was published by Stanley Kay and colleagues in 1987 and is a widely
used instrument in both psychiatric research and clinical praxis [Kay et al., 1987]. The
test interview takes 45 to 60 minutes and must be conducted by a psychological or med-
ical professional, specifically trained for this instrument.
The PANSS was designed to detect the different qualities of symptoms in schizophrenia.
Accordingly, the positive scale consists of 7 items that examine ’positive’ symptoms such
as delusions, hallucinations or hyperactivity, whilst the negative scale covers 7 symptoms
like emotional withdrawal and blunted affect. The general psychopathology scale detects
a variety of 16 other pathologies, such as anxiety, disorientation or poor impulse control.
Each item is rated by the interviewer with 1 to 7 points depending on the severity of the
respective symptom. Hence, the sum score for each scale varies as follows: positive scale:
7 to 49 points, negative scale: 7 to 49 points, general psychopathology scale: 16 to 112
points. When originally tested on patients with schizophrenia by Kayle and colleagues in
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1987, the mean scores were 18.20 points on the positive scale, 21.01 points on the negative
scale and 37.74 points on the general psychopathology scale [Kay et al., 1987].
Global Assessment of Functioning - Symptoms and Disability/Impairment
The Global Assessment of Functioning (GAF) is a scale used to determine the level of
functioning of the subject being examined. In this context, ’functioning’ refers to the
ability to cope with the diverse problems one encounters in one’s social, occupational and
psychological environments [Hall, 1995]. The GAF is rated by the clinician/interviewer,
based on their evaluation of the patient’s respective level of functioning. Scores range
between 1 and 100, with 1 to 10 being the lowest and 91 to 100 being the highest
score. In the PRONIA Study, the GAF is further divided into two assessments: GAF-
Symptoms and GAF-Disability/Impairment. Here, the GAF-Symptoms focuses on the
subject’s actual symptoms, their severity and their impact on the subject’s functioning.
The GAF-Disability/Impairment takes into account the level of disability or impairment
the subject suffers due to its mental health disorder.
3.4 The Neuropsychological Test Battery
All neuropsychological data examined in this study was collected using the standard
PRONIA Neuropsychological Test Battery. This protocol consists of 15 neuropsycholog-
ical assessments covering the domains speed of processing, attention, working memory,
verbal and visual learning, social cognition, executive functions, salience attribution and
premorbid IQ (Table 6).
Testing was conducted by trained psychologists and medical professionals using a tablet-
computer running custom software programmed in PEBL (The Psychology Experiment
Building Language; http://pebl.sourceforge.net/) set-up as well as pen and paper ver-
sions. Testing took about 120 minutes for completion with an optional 5 minutes break
after 60 minutes. Participants were instructed not to consume any psychoactive or stim-
ulating substances before or during testing (e.g. caffeine, alcohol).
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Cognitive domain Assessment Format
Speed of processing Digit Symbol Substitution Test p&p
Trail Making Test A p&p
Phonemic Verbal Fluency Task p&p
Attention Continuous Performance Test - Identical Pairs PEBL
Working memory Forward and Backward Digit Span PEBL
Self-Ordered Pointing Test PEBL
Verbal learning Rey Auditory Verbal Learning Test PEBL
Visual learning Rey-Osterrieth Complex Figure Test p&p
Social cognition Diagnostic Analysis of Nonverbal Accuracy - 2nd
Version
PEBL
Executive functions Trail Making Test B p&p
Semantic Verbal Fluency Task p&p
Salience attribution Salience Attribution Test PEBL
Premorbid IQ Wechsler Adult Intelligence Scale, Vocabulary p&p
Wechsler Adult Intelligence Scale, Matrices p&p
Table 6: Cognitive domains and neuropsychological assessments. The Salience
Attribution Test can also be assigned to the domain ’reward processing’. PEBL: tablet-
based testing format; p&p: pen and paper version.
Rey-Osterrieth Complex Figure Test (ROCF) Originally invented in order to
detect and quantify cognitive deficits in patients with traumatic brain injury, the Rey
Complex Figure Test has been further developed and applied in different neuropsycho-
logical examinations, in order to tackle various problems [Rey, 1941]. In the PRONIA
Neuropsychological Test Battery, we used the updated version by Paul-Alexandre Oster-
rieth, as it has been shown to detect specific cognitive deficits in both schizophrenia as
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well as bipolar psychosis [Seidman et al., 2003].
When performing the ROCF, the examinee is asked in a first step to accurately copy a
standardized geometrical figure shown on the tablet computer. In a subsequent second
step, the participant has to produce another accurate copy of said image from his mem-
ory. After a 20 to 30 minutes delay, the participant is asked to again draw the image
from his memory in a third and final step.
Altogether, the ROCF takes about 10 to 15 minutes to complete without taking the de-
lay into account. Scoring was performed according to the guidelines developed by Taylor
[Strauss et al., 2006]. Here the test figure is divided into 18 different subitems and which
are then rated for completeness/accuracy and correct placement. In total we obtained 66
test features with time of completion for every one of the three steps being a PRONIA-
specific feature originally not being surveyed in the ROCF. All examiners conducting and
scoring the ROCF completed and passed a test for interrater reliability.
Diagnostic Analysis of Nonverbal Accuracy - 2nd Version (DANVA) The
DANVA is a test examining the social cognition in which the examinee is presented
with 24 pictures of adult faces to which he has to assign one of the basic emotions happi-
ness, sadness, anger or fear [Nowicki and Duke, 2001]. Whilst the original DANVA also
consists of three additional subtests (child faces, child paralanguage, adult paralanguage)
the PRONIA Neuropsychological Test Battery limits itself to adult faces. The exam-
ination is conducted solely through the PEBL tablet application and the participants
enter their answers by operating the tablet touch screen. Before testing, the participant
performs one training run under the supervision of the examiner. For the time of testing
the examiner must not speak to the participant nor influence him in any other way.
Forward and Backward Digit Span Task (FDS and BDS) The FDS/BDS are
tasks examining the working memory and number processing skills of a subject. In these
tasks, an audio file reads a series of numbers which the examinee has to immediately re-
peat to the examiner, who enters the subject’s answers into the tablet computer (FDS).
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With every two correctly repeated series of numbers the PEBL test software adds one
additional number to the digit span. The test ends once the examinee failed two con-
secutive times to correctly repeat the series of numbers. In a second step, the subject
is asked to repeat the numbers presented to him backwards (BDS). Depending on the
subject’s performance, this task takes 5 to 10 minutes for each subtest (FDS, BDS). We
collected two kinds of measures in this test: (i) maximum digit string length reminded at
least once and (ii) number of correct trials.
Semantic and Phonemic Verbal Fluency Task (PVF and SVF) Previous stud-
ies suggest that schizophrenic patients tend to present cognitive impairments in both
semantic and phonemic verbal fluency [Aloia et al., 1996, Kremen et al., 2003]. Hence,
in order to build on these findings the SVF and PVF were implemented in the PRONIA
Neuropsychological Test Battery.
In the SVF - as in the PVF - the examinee is asked to produce as many words in 60
seconds with a certain characteristic as possible. In the SVF, these words have to be
attributed to a specific category - in our case ’animals’. Furthermore, the subject is in-
structed not to repeat any words, nor to name groups of words that belong to the same
semantic family. In the PVF, the participant is asked to list words that all start with the
same letter - in our case the letter ’S’. Here, the semantic category of the words are of
no importance.
Testing itself was conducted with the examiner writing down the words given by the par-
ticipant while the tablet computer simultaneously voice recorded the subject’s answers.
At the beginning and the end of the 60 seconds time span, the tablet computer would
make a beeping sound to indicate start and end of the exam. After testing, the examiner
compared the written notes with the recorded audio files and scored the number of cor-
rect, as well as incorrect and repeated words. Collected measures were: correct , error
and repeated words within the time spans 0 to 15 seconds, 16 to 30 seconds, 31 to 45
seconds, 46 to 60 seconds and 0 to 60 seconds in sum.
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Rey Auditory Verbal Learning Test (RAVLT) In order to cover verbal learning as
cognitive domain in our neuropsychological trials we implemented the RAVLT. This test
is widely used in academia as well as clinical work as it provides a comprehensive under-
standing of the examinee’s performance concerning short term auditory verbal learning
memory, learning strategies and memory processing [Schmidt et al., 1996].
When conducting the RAVLT, the participant is given a list of 15 unrelated words (list
A) presented to him by an audio file on the tablet computer. The participant is then
asked to directly repeat as many of the 15 words as possible. The order in which the
examinee repeats the words is of no concern. However, it is recorded if the participant
repeats himself and names a certain word twice or more. In total, this part of the RAVLT
repeats itself five times. After that the participant is presented with a different list of
15 unrelated words once (list B) and is again asked to repeat these words immediately
after hearing the list out. Again, the examiner scores every word named by the subject.
However, this time it is also noted if words from list A are being produced. In a next
step, the participant is asked to again repeat all words from list A, without hearing list
A again. Lastly, after a 20 to 30 minutes interval, the participant is again asked to re-
produce as many words from list A as possible.
Altogether, the RAVLT takes about 15 to 20 minutes for completion, not taking into
account the break interval.
In our analysis, due to a systematic error in the PEBL test set-up the variable ’Recogni-
tion words from list A’ had to be excluded from all subsequent analyses.
Trail Making Test A + B (TMTA/TMTB) Testing the cognitive domains speed
of processing (TMTA) and executive functions (TMTB), these neuropsychological tasks
have been widely used and implemented in research, clinical work and even military ad-
mission tests [Tombaugh, 2004].
In the TMTA the participant is required to connect the numbers 1 to 25 spread randomly
on a paper as quickly as possible. Furthermore, the examinee is instructed not to lift the
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pen off the paper nor to turn or spin the exercise sheet once he has started the exercise.
The exact task differs slightly in the TMTB, as the participant is now asked to connect
numbers and letters in an alternating order (1-A-2-B-3-etc.). For both tasks the examiner
records the time of completion, the number of violations (e.g. interrupting the exercise,
turning the page etc.) and the number of errors (e.g. connecting the wrong dots). During
the exercise, the examiner must oversee the participant’s performance and - if needed -
correct the examinee in case of errors or violations. In case of an error, the participant
is to return to the last correct number and proceed from this point on.
Both tasks start off with a shortened example exercise to ensure the participant’s under-
standing of the task’s rules. For both, the TMTA and B the measures Time of completion,
Errors and Violations were recorded.
Continuous Performance Test - Identical Pairs (CPT-IP) The CPT-IP has been
widely used and investigated in the framework of schizophrenia and depression research
and has shown to be a serviceable tool in detecting cognitive deficits in attention and
working memory [Cornblatt et al., 1989, Cornblatt et al., 1988].
In this task we test for the examinee’s ability to maintain attention and short-term
memory capacity. After a short supervised test trial with 3 digits, the examinee is
confronted with the actual task. Here, the participant is presented with rapidly flashing
strings of 4 digits on the tablet screen. Whenever two identical strings of digits appear
consecutively, the participant is to respond by clicking the left mouse button.
In total, there are 300 trials, 20% of which contain a target to which the examinee
is expected to respond. Furthermore, there were 20% of catch-trials which are similar
but not identical strings of digits. The PEBL program measures the number of correct
responses (positive and negative response) as well as errors regarding distracting stimuli,
filler stimuli and omissions. Additionally, the tablet computer records the participant’s
reaction times whenever there is a positive response (clicking of the mouse button).
For the univariate statistical analysis I further calculated the discriminability index d’ in
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order to better assess test performance. Precisely, d’ is the ratio between hits at positive
response and catch-trials and is calculated as d′ = µp−µc√
1
2
(σp+σc)
, with µp and σp and µc
and σc being the mean and standard deviation of correct positive response hits and false
catch-trial hits, respectively [Macmillan and Creelman, 2004].
Consequently, I receive a statistical feature focusing especially on attentional processing
[Mirzakhanian et al., 2013, Roitman et al., 1997].
Self-Ordered Pointing Test (SOPT) Originally developed by Petrides and Milner
in order to test for working memory deficits in patients with frontal lobe brain lesions,
the SOPT has become a popular tool in testing executive working memory in both chil-
dren and adults [Petrides and Milner, 1982, Cragg and Nation, 2007]. In each trial of our
version of the SOPT, the participant is presented with an array of 4, 6, 8 or 10 different
symbols and is instructed to click each individual symbol exactly once. After every click
the symbols will rearrange, forcing the examinee to exactly remember which symbols
have already been clicked and which have not. The task starts off with the examiner
supervising a test trial of 4 simple geometrical symbols. This test trial is conducted
3 times to ensure the participant’s understanding of the task. In the actual task, the
participant is confronted with first 4 then 6, 8 and 10 abstract symbols. Each trial is
conducted three times. As variables, for each trial the tablet computer registers errors,
perseveration errors and maximum correct responses before error.
Digit Symbol Substitution Test (DSST) Being a fast and simple testing instru-
ment, the DSST has found its way into a multitude of neuropsychological test batteries
(e.g. Brief assessment of cognition in schizophrenia [Keefe et al., 2004], Wechsler Adult
Intelligence Scale [Wechsler, 2014]).
In this task, the participant is presented with 9 symbols, each accompanied by a corre-
sponding digit (1 to 9). To complete the task, the participant is now given 90 seconds to
add as many of the corresponding digits to a string of symbols as possible. In doing so,
the participant has to ’translate’ one symbol after another. After 90 seconds, the task
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ends and the examiner records both, the number of correct answers and the errors.
Wechsler Adult Intelligence Scale, Vocabulary (WAIS-V) In order to assess the
verbal IQ of the study participants, we implemented the Vocabulary test of the WAIS
[Wechsler, 2014]. Here, the examinee is asked to explain a total of 33 words. The examiner
scores the answers given using a standardized manual. Depending on the correctness of
the response, the participant can achieve either 0, 1 or 2 points per answer, with two
being the best result. Thus, the maximum obtainable raw score is 66. In a second step,
the raw score is standardized to age according to the official WAIS scoring tables. Hereby,
combined with the Wechsler Adult Intelligence Scale - Matrices, we expect to obtain a
representative estimation of the premorbid IQ of each participant.
Wechsler Adult Intelligence Scale, Matrices (WAIS-M) Testing for non-verbal
reasoning and IQ as well as visuo-spatial reasoning, this task in combination with the
WAIS-V allows us to estimate the participant’s premorbid IQ. The test itself is conducted
using the official WAIS-Matrices charts. Here, the study participant is asked to complete
the missing piece of a Matrix or row of symbols by choosing one of five given options. In
total, there are 26 trials and a total of 26 achievable points maximum. The raw score is
corrected for age using the official WAIS scoring tables. Both, the WAIS-V and WAIS-
M are pen and paper versions. In this study, we used the official WAIS test materials.
Both tests were conducted in German or English, depending on the study participant’s
preference and/or linguistic abilities.
Salience Attribution Test (SAT) In previous studies, this instrument has been
shown to be a sensitive tool in revealing aberrant salience attribution in psychotic disor-
ders such as schizophrenia [Roiser et al., 2009]. However, due to technical difficulties at
the time of data analysis, this specific task did not find its way into the study at hand,
since data needed further processing to be recoverable. Therefore, I refrain from going
into the complex details of the structure and execution of the SAT.
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3.5 Statistical Analysis
3.5.1 Univariate Analysis
For all univariate statistical analyses we used SPSS 15.0 for Windows. In order to ex-
amine group differences in ROD vs. ROP, univariate statistics two-sample t-tests were
performed on a number of 23 variables. Significance was assumed for P ≤ 0.05.
In order to avoid statistical error we corrected for multiple comparisons using the Bon-
ferroni correction. Thus, the p-value was further divided by the number of comparisons
conducted, giving us P ≤ 0.05/(23) = P ≤ 0.00217. For a detailed list of statistical
variables analyzed, see Table 7.
Cognitive domain Assessment Variables
Speed of processing DSST Raw score correct
TMTA Time of completion
PVF Sum correct responses
Attention CPT-IP D prime (d’ )
Working memory FDS/BDS Sum raw score correct
SOPT Mean error score trial 10 items
Verbal learning RAVLT Raw score trial 1 to 5
Sum raw score 1 to 5
Sum out of list words 1 to 5
Raw score after interference list
Raw score delayed repetition
Visual learning ROCF Raw score copy
Raw score immediate memory
Raw score delayed memory
Social cognition DANVA Raw score correct
Executive functions TMTB Time of completion
SVF Sum correct responses
Premorbid IQ WAIS-V Standardized Score
WAIS-M Standardized Score
Table 7: List of univariate variables. Note: Variables were chosen according to
[Koutsouleris et al., 2011].
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3.5.2 Multivariate Analysis (MVA)
All multivariate analyses were conducted using NeuroMiner©, a MATLAB-based fully
automated machine learning software developed by Nikolaos Koutsouleris
(cf. [Koutsouleris et al., 2014]).
In total we conducted 3 different analyses:
i) ROD vs. ROP using the 23 variables prior examined by univariate statistics,
ii) ROD vs. ROP using 214 variables collected by the PRONIA Neuropsychological
Test Battery,
iii) Leave-Center-Out.
Each one of the analyses provides us with the measures classification accuracy, sensitivity
and specificity. Additionally, NeuroMiner presents a list of variables most decisive to
the classification process, permitting a further insight on the respective, illness-specific
neurocognitive performance patterns.
In this study, we refrained from correcting the data for age, sex or level of education since
the pool of Healthy Controls (HC) at the time of analysis was too sparse and did not
allow for a valid statistical standardization.
Support Vector Machine (SVM) To create optimized models for diagnostic differen-
tiation we utilized a L2-regularized support vector machine (SVM) from the LIBLINEAR
toolbox implemented in NeuroMiner (see [Fan et al., 2008]). Methodologically, the SVM
differentiates between the ROD and ROP groups by estimating a boundary between the
two groups in which the support vectors mark the maximum distance between the most
similar subjects of the opposite study populations [Koutsouleris et al., 2011]. See chapter
2.5.1 for a detailed explanation of the SVM’s functionality.
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Cross-validation (CV) Training and testing of the SVM was performed within a
repeated nested cross-validation analysis (CV) [Filzmoser et al., 2009]. Here, our data-
set is split into an inner (CV1) and outer (CV2) cross-validation. Each CV in itself is
folded into 5 permutations x 10 folds of non-overlapping samples. In the CV1, these n
folds function as training sets for the different parameter set-ups of the SVM with the
n − 1th fold being a test sample to validate each model’s classification accuracy. For
the purpose of detecting generalization errors, the best performing models generated
in CV1 are then applied to the outer cross-validation. To assure the validity of said
generalization analysis, all training and test samples were kept strictly separated (cf.
[Zarogianni et al., 2013]).
Parameter Set-up Firstly, all data with zero variance was pruned from the data-
set as these are redundant and hold no information for machine learning algorithms.
Secondly, for subjects with less than 25% of missing data, missing values were im-
puted. The imputed data was calculated as the median value of the missing data,
based on the values of the 7 nearest neighbours according to the Euclidian distance
(cf. [Beretta and Santaniello, 2016]). Lastly, all data was scaled from -1 to 1 as this is
demanded by LIBLINEAR SVM.
The SVM was fed with a range of slack variables. These slack variables were defined
as 2[−5:2:11]. Consequently, the SVM tried different slack variable (or C parameter) set-
ups (2−5; 2−3; 2−1;...; 29; 211)on the CV1 and thereby defining different penalties for
misclassifying subjects.
Feature selection To optimize model predictions in the CV1, it is possible to apply
additional feature selection filters [Saeys et al., 2007]. In this work, I engaged a wrapper
method with Greedy feature selection [John et al., 1994]. More specifically, I set up a
forward stepping wrapper, up to 90% of the features in steps of 5%. The wrapper method
was applied to the CV1 train and test partitions. Hereby, the SVM is presented with an
iteratively increasing number of features and thus can detect the optimal conditions for
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its classification models.
ROD vs. ROP Analysis - 23 variables As mentioned at the beginning of this
chapter, I conducted 3 different multivariate analyses. In this first analysis, I aim to
compare the multivariate classification performance between ROD and ROP subjects to
our univariate statistics. Therefore, the analysis is restricted to the same 23 neurocogni-
tive variables that are tested using the two-sampled t-tests. Classification is performed
on all 116 available subjects.
ROD vs. ROP Analysis - 214 variables This second analysis investigates differ-
ential diagnostic performance between ROD and ROP in the framework of a much more
comprehensive data-set (214 variables). Apart from the number of neurocognitive vari-
ables, all settings and subjects are identical to the 23-variables-analysis. A detailed list
of the variables examined in this analysis can be found in the appendix.
Leave-Center-Out Analysis Finally, in order to test our classification models for
multisite generalizability, I implemented a leave-center-out analysis. In this analysis, the
SVM trains its models on data of only 4 of the 5 PRONIA study centers. The generated
models are then applied to the data of the remaining study center in the CV2 test parti-
tions. This is conducted for each of the centers as testing data, hence providing us with 5
different classification accuracies. For a measure of generalizability, these accuracies are
then averaged.
In this analysis we use the same parameter setup and the same 214 variables as in the
’ROD vs. ROP - 214 variables’ analysis to achieve maximum comparability.
43
4 Results
4.1 Demographic Data Analysis
To compare our 2 study groups in terms of illness-specific biometric scores, we performed
2-sample t-tests with ROD vs. ROP data on BDI, PANSS, GAF-S and GAF-DI scores
(see Table 5 ). Significance was estimated for P ≤ 0.05.
Participants with recent onset depression did not score significantly higher on the Beck
Depression Inventory - II than subjects with recent onset psychosis (mean score ROD:
25.7± 13.1; mean score ROP: 24.6± 12.3). However, both groups classify as ’moderate’
to ’severe’ depression when comparing the mean scores to the benchmarks as described
in previous literature (see chapter 3.3).
Concerning the Positive and Negative Syndrome Scale, ROP patients in average scored
significantly higher than ROD patients in the PANSS total measure as well as all 3 sub-
scales positive, negative and general symptoms. With mean scores of 19.5 ± 6.0 in the
PANSS positive, 17.2± 7.3 in the PANSS negative and 37.7± 10.0 in the PANSS general
subscale, the ROD group scores well in line the schizophrenic patients tested by Kayle
and colleagues in 1987, with only the mean score in the PANSS negative lying below the
correspondent score in literature (21.01 points).
Regarding the Global Assessment of Functioning, ROP subjects presented with a signifi-
cantly lower level of functioning than ROD subjects in both scales, GAF-S and GAF-DI,
indicating a generally lower level of functioning in the ROP group as compared to ROD
subjects.
In order to attain an approximate measure for the premorbid IQ, we compared the WAIS-
A (averaged score of WAIS-V and WAIS-M) of the two groups. Here, ROD participants
again scored significantly higher than ROP patients (mean scores: 11.0±2.3 and 8.99±2.6,
respectively).
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4.2 Univariate Analysis Results
Examining the cognitive domain verbal learning , we found significant results especially
in comparing the sum scores of correctly remembered words throughout the first 5 trials
of the task (RAVLT Sum Raw Score 1-5). Here, ROD patients scored significantly higher
on average (58.3 ± 8.6) than their study counterparts with a mean score of 52.1 ± 12.1.
On a single trial level, in particular trials 2 and 4 showed significant results (Table 8 ).
In the variables for ’out of list words’, raw score after the interference list and delayed
repetition, no significant performance disparities could be detected.
In summary, it can be stated that in comparison ROP subjects perform worse in the
cognitive domain verbal learning than subjects with recent onset depression.
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Figure 5: Box plot RAVLT Sum Score trial 1 to 5. This variable is a sum score
of the variables RAVLT Raw Score trial 1 to 5. Boxplots visualizing means, standard
deviation, maximum and minimum scores. y-axis: Sum of Raw Score Trial 1 to 5; x-axis:
ROD vs. ROP.
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For sustained and onward attention , we compared the mean performances on the dis-
criminability index d’. Here the ROD group presented an average score of 2.49 ± 0.78,
whereas ROP subjects reached a score of 1.96± 0.71. Again, this results is to be consid-
ered significant for P < 0.00217.
Accordingly, subjects suffering from depression exhibit a greater ability to identify stim-
uli to which they have to react, while dismissing false stimuli, than patients suffering
from psychotic symptoms. Furthermore, depressive patients seem to be more capable in
keeping their attention up over a longer time span.
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Figure 6: Box plot CPT-IP D prime (d’). Boxplots visualizing means, standard
deviation, maximum and minimum scores. y-axis: D prime (d’); x-axis: ROD vs. ROP.
See Table 8 for exact measures.
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By investigating the means of the ’FDS/BDS Sum Raw Score correct’ and ’SOPT Mean
error score 10 items’ we can draw conclusions concerning potential group differences in
working memory abilities. However, neither in the FDS/BDS sum score nor in the
SOPT mean errors variable significant group differences could be revealed (11.3± 2.1 vs.
10.2± 2.0 and 1.63± 1.0 vs. 2.0± 0.88, respectively).
Social cognition was examined by comparing the mean ’DANVA Raw score correct’
of each study group. ROD subjects on average reached a score of 19.4 ± 1.9 and ROP
subject attained a mean score of 18.1±2.9. While these values seem to present a notable
difference, statistical significance could not be attested with P = 0.003.
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Figure 7: Box plot DANVA Raw Score correct. Boxplots visualizing means, stan-
dard deviation, maximum and minimum scores. y-axis: DANVA Raw Score correct;
x-axis: ROD vs. ROP. Mean differences were not statistically significant. See Table 8 for
exact measures.
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In the domain speed of processing , we analyzed variables from 3 different tasks: ’DSST
Raw Score correct’, ’TMTA Time of completion’ and ’PVF Sum correct responses’. Of
these 3 variables, only the Digit Symbol Substitution Test produces significant perfor-
mance differences between the two study groups (ROD mean: 62.9 ± 11.0; ROP mean:
50.2 ± 12.6). With a respective P -value of 0.027 and 0.011 these results could not be
confirmed when comparing the time of completion in the TMT A or the sum of correct
responses in the PVF as additional measures for the speed of processing.
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Figure 8: Box plot DSST Raw Score. Boxplots visualizing means, standard deviation,
maximum and minimum scores. y-axis: Raw Score of correctly translated symbols; x-axis:
ROD vs. ROP. See Table 8 for exact measures.
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As mentioned before, the Rey-Osterrieth Complex Figure Test primarily covers the cog-
nitive process of visual learning . Accordingly, we investigated the participant’s per-
formance in the three trials direct copy, immediate recall and delayed recall. While all
three trials show slightly higher scores for the ROD group (34.0 ± 3.0 vs. 32.7 ± 5.2,
23.7± 6.4 vs. 21.7± 9.5 and 23.4± 6.3 vs. 22.1± 9.2), none of these guarantee statistical
significance.
Hence, neither depressive, nor psychotic patients seem to perform generally higher or
lower than subjects from the respective opposite group.
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Figure 9: Box plot ROCF copy, immediate and delayed. Boxplots visualizing
means, standard deviation, maximum and minimum scores. ROCF 1: Trial 1 copy;
ROCF 2: Trial 2 immediate memory; ROCF 3: Trial 3 delayed memory. y-axis: ROCF
Raw Score correct; x-axis: ROD vs. ROP. for each trial. See Table 8 for exact measures.
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Executive functionality disparities in the two study groups were highlighted by per-
forming 2-sample t-tests on the ’TMT B Time of completion’ variable and the sum of
correct responses in the Semantic Verbal Fluency Task. Here, with average completion
times of 60.9± 25.5 vs. 82.5± 42.1 seconds in the TMT B and 24.7± 6.7 vs. 20.9± 6.1
correct responses in the SVF we were able to identify performance differences between
both groups.
Thus, these results suggest that patients with recent onset depression preserve a higher
executive functionality than recent onset psychotic individuals.
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Figure 10: Box plot TMT B Time of completion. Boxplots visualizing means,
standard deviation, maximum and minimum scores. y-axis: Time of completion for the
TMT B in seconds; x-axis: ROD vs. ROP. See Table 8 for exact measures.
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Figure 11: Box plot SVF Sum correct responses. Boxplots visualizing means,
standard deviation, maximum and minimum scores. y-axis: Sum of correct responses;
x-axis: ROD vs. ROP. See Table 8 for exact measures.
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We compared the overall performance of the two study populations on the WAIS-V and
WAIS-M in order to receive an approximate measure for group differences concerning
the premorbid IQ . Results were significant for both variables. Participants with recent
onset depression scored almost 2 points higher on average than participants with recent
onset psychosis, with the respective means being ROD vs. ROP: 11.0± 2.8 vs. 9.1± 3.6
in the WAIS-V and 11.0± 2.4 vs. 8.9± 2.6 in the WAIS-M.
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Figure 12: Box plot WAIS Vocabulary/Matrices. Means, standard deviation, max-
imum and minimum in the WAIS Vocabulary (WAIS-V) and Matrices (WAIS-M) for
ROD and ROP group. See Table 8 for exact measures.
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Variables
ROD
mean
(sd)
ROP
mean
(sd)
t df P
RAVLT Raw Score trial 1 8.2 (2.3) 7.2 (2.7) 2.204 114 0.030
RAVLT Raw Score trial 2 11.3 (2.5) 9.7 (2.9) 3.184 114 0.00*
RAVLT Raw Score trial 3 12.4 (2.2) 11.2 (2.7) 2.701 108.83 0.008
RAVLT Raw Score trial 4 13.0 (1.9) 11.7 (2.6) 3.229 104.42 0.00*
RAVLT Raw Score trial 5 13.4 (1.8) 12.4 (2.6) 2.318 101.91 0.022
RAVLT Sum Raw Score 1-5 58.3 (8.6) 52.1 (12.1) 3.170 102.65 0.00*
RAVLT Sum out of list words 1-5 0.95 (2.1) 1.29 (3.5) 0.649 114 0.518
RAVLT Raw Score interference list 12.5 (2.4) 11.2 (3.1) 2.408 114 0.018
RAVLT Raw Score delayed repet. 12.5 (2.3) 10.8 (3.5) 3.065 99.17 0.003
FDS/BDS Sum Raw Score correct 11.3 (2.1) 10.2 (2.0) 2.946 114 0.004
CPT-IP D prime (d’) 2.49 (0.78) 1.96 (0.71) 3.874 114 0.00*
DANVA Raw Score correct 19.4 (1.9) 18.1 (2.9) 3.049 114 0.003
DSST Raw Score correct 62.9 (11.0) 50.2 (12.6) 5.815 114 0.00*
PVF Sum correct responses 14.6 (4.5) 12.2 (5.5) 2.582 109.89 0.011
SVF Sum correct responses 24.7 (6.7) 20.9 (6.1) 3.248 114 0.00*
ROCF Raw Score copy 34.0 (3.0) 32.7 (5.2) 1.689 90.17 0.094
ROCF Raw Score immediate 23.7 (6.4) 21.7 (9.5) 1.331 99.93 0.186
ROCF Raw Score delayed 23.4 (6.3) 22.1 (9.2) 0.871 100.97 0.386
SOPT Mean error score 10 items 1.63 (1.0) 2.0 (0.88) -2.359 114 0.020
TMTA Time of completion 29.1 (11.0) 34.7 (15.2) -2.241 113 0.027
TMTB Time of completion 60.9 (25.5) 82.5 (42.7) -3.309 93.16 0.00*
WAIS-V Standardized Score 11.0 (2.8) 9.1 (3.6) 3.168 105.5 0.00*
WAIS-M Standardized Score 11.0 (2.4) 8.9 (2.6) 4.528 114 0.00*
Table 8: Univariate Analysis Results. sd = standard deviation; t = t-value; df =
degrees of freedom; P = p-value. *Significant at P < 0.00217 according to Bonferroni
correction for multiple comparisons.
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4.3 Multivariate Analysis Results
4.3.1 ROD vs. ROP - 23 variables
In the ROD vs. ROP - 23 variables analysis we trained an SVM algorithm to classify
subject groups based exclusively on data for the 23 neuropsychological variables that are
examined in the prior univariate analysis (Table 7 ).
Here, of 58 patients with recent onset depression 41 have been rightly identified as such.
Accordingly, 17 depressive patients have been misclassified as recent onset psychotic
(ROP) subjects. Of the 58 ROP patients, 33 have been correctly assigned by the clas-
sifier to their respective category. However, a total of 25 ROP patients were wrongly
categorized as subjects with recent onset depression.
As a result, we obtain an overall accuracy of 63.8% with a sensitivity of 70.7% and
a specificity of 56.9%. The positive predictive value reaches 62.1% and the negative
predictive value 66.0%. A detailed list of results can be found in Table 9.
Variable Results
ROD (n) 58
ROP (n) 58
True positive (TP) 41
True negative (TN) 33
False positive (FP) 25
False negative (FN) 17
Accuracy [%] 63.8
Sensitivity [%] 70.7
Specificity [%] 56.9
Balanced Accuracy [%] 63.8
Area under the Curve 0.72
Positive Predictive Value [%] 62.1
Negative Predictive Value [%] 66.0
Table 9: Results ROD vs. ROP - 23 variables.
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In Figure 9 the SVM’s prediction scores for each subject individually are displayed.
Figure 13: Distribution plot ROD vs. ROP - 23 variables. On the x-axis all
116 subjects are displayed according to their subject number. On the y-axis we see the
’Prediction Score’ or likelihood-ratio that lead to classification. A positive Prediction
Score indicates classification as ROD, a negative score as ROP. Blue circles: correctly
classified ROD; Red circles: correctly classified ROP; Blue stars: misclassified ROD; Red
stars misclassified ROP.
55
Most decisive variables for classification Another highly interesting aspect of the
MVA is the possibility to identify which variables had the biggest decision value or feature
weight in the SVM’s decision-making.
Hence, variables with high feature weights in this specific analysis can be considered to
contain relatively more illness-specific information than other variables analyzed by the
SVM. A list of the 10 most decisive variables in the analysis at hand can be found in the
Table 10 :
Neuropsychological variable:
1. DSST Raw Score correct
2. WAIS-V Standardized Score
3. CPT-IP D prime (d’)
4. FDS/BDS Sum Raw Score correct
5. ROCF Raw Score delayed
6. WAIS-M Standardized Score
7. RAVLT Raw Score trial 3
8. ROCF Raw Score immediate
9. RAVLT Raw Score interference list
10. RAVLT Sum out of list words 1-5
Table 10: ROD vs. ROP - 23 variables analysis: 10 most decisive variables.
Variables are listed in a decreasing order of feature weight.
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4.3.2 ROD vs. ROP - 214 variables
In this second neurocognitive pattern analysis we trained our SVM classifier on all 214
variables recorded throughout the PRONIA Neuropsychological Test Battery.
In this analysis, of 58 ROD subjects 42 were correctly classified as patients with depres-
sion (True positive = TP). 16 ROD subjects were falsely appointed to the recent onset
psychosis group, giving us a False negative (FN) number of 16. Regarding the ROP
group, 41 subjects were accurately classified as such, while 17 ROP subjects were incor-
rectly recognized as ROD subjects.
Consequently, in this analysis we achieved an overall classification accuracy of 71.6%,
with a sensitivity of 72.4% and a specificity of 70.7%. The positive and negative pre-
dictive values were set at 71.2% and 71.9%, respectively.
Variable Results
ROD (n) 58
ROP (n) 58
True positive (TP) 42
True negative (TN) 41
False positive (FP) 17
False negative (FN) 16
Accuracy [%] 71.6
Sensitivity [%] 72.4
Specificity [%] 70.7
Balanced Accuracy [%] 71.6
Area under the Curve 0.76
Positive Predictive Value [%] 71.2
Negative Predictive Value [%] 71.9
Table 11: Results ROD vs. ROP - 214 variables.
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In Figure 10, again the SVM algorithm’s prediction score for each subject individually is
displayed in a distribution plot.
Figure 14: Distribution plot ROD vs. ROP - 214 variables. On the x-axis all
116 subjects are displayed according to their subject number. On the y-axis we see the
’Prediction Score’ or likelihood-ratio that lead to classification. A positive Prediction
Score indicates classification as ROD, a negative score as ROP. Blue circles: correctly
classified ROD; Red circles: correctly classified ROP; Blue stars: misclassified ROD; Red
stars misclassified ROP.
58
Most decisive variables for classification Since the data pool based on which the
support vector machine trained its classification models is much more comprehensive in
this analysis, it becomes even more interesting to highlight those neuropsychological vari-
ables with the greatest impact on the SVMs’ models.
A list of the 15 most decisive variables can be found in Table 12 :
Neuropsychological variable:
1. SOPT Errors 6 elements 02
2. WAIS-M Standardized Score
3. DANVA Raw Score correct
4. CPT-IP Reaction times correct 50 trials
5. CPT-IP Number correct 200 trials
6. WAIS-V Standardized Score
7. CPT-IP Number error filler stimuli 200 trials
8. SOPT Perseveration Errors 10 elements 03
9. DSST Correct number symbol matchings
10. PVF Correct 45 60 letter 1
11. DSST Raw score correct
12. CPT-IP Number correct 150 trials
13. TMTA Time of completion
14. RAVLT Immediate 5 repetition list A
15. SVF Error 15 30 category 1
Table 12: ROD vs. ROP - 214 variables analysis: 15 most decisive variables.
Variables are listed in a decreasing order of feature weight. See chapter 7 ’Appendix’ for
a list of all 214 variables.
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4.3.3 Leave-center-out Analysis
As described in the paragraph ’Leave-center-out Analysis’ in chapter 3.5.2, this analy-
sis is primarily performed in order to quantify the classifiers’ generalizability within the
framework of a multicenter data pool. Hence, the question at hand is whether our clas-
sifier actually limits itself to differentiate between, in this case, disease-specific patterns
or whether it also takes into account each subjects’ center affiliation.
Subjects from one center are classified based on classification models that have been solely
trained on data from the 4 remaining centers. Consequently, classification results in this
analysis become a measure of generalizability.
Across all 5 sub-analyses, 42 of 58 subjects of both study groups were correctly classi-
fied and 16 of 58 subjects were falsely appointed to the opposite study group. Thus, we
achieved an overall accuracy of 72.4% with a sensitivity of 72.4% and a corresponding
specificity of 72.4%.
Variable Results
ROD (n) 58
ROP (n) 58
True positive (TP) 42
True negative (TN) 42
False positive (FP) 16
False negative (FN) 16
Accuracy [%] 72.4
Sensitivity [%] 72.4
Specificity [%] 72.4
Balanced Accuracy [%] 72.4
Area under the Curve 0.78
Positive Predictive Value [%] 72.4
Negative Predictive Value [%] 72.4
Table 13: Results Leave-center-out Analysis
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When looking at the results of the Leave-center-out analysis individually, it becomes ap-
parent that classification generalizability differs depending on the center the models are
tested on.
Here, highest accuracies with 82.1% are achieved when classifiers are trained on the
centers LMU, UBS, Uni BHAM and Uni Udine and then tested on subjects from UKK.
While results for Uni Udine and LMU (76.5% and 73.2%, respectively) as test data lie
close to the overall accuracy of 72.4%, subjects from Uni BHAM and especially UBS
are much more likely to be misclassified with accuracies of 62.5% and 59.1%, respectively.
LMU UBS UKK Uni
BHAM
Uni
Udine
TOTAL
Accuracy [%] 73.2 59.1 82.1 62.5 76.5 72.4
Sensitivity [%] 75.0 50.0 80.0 50.0 83.3 72.4
Specificity [%] 70.5 66.7 83.3 66.7 60.0 72.4
Table 14: Leave-center-out Analysis: Results for each center independently.
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5 Discussion
5.1 Summary of the Findings
The first aim of the study was to identify differences in the performance on the PRONIA
Neuropsychological Test Battery between ROD and ROP subjects by comparing the re-
spective test results conducting 2-sample t-tests. Significance in performance differences
was assumed for P < 0.00217 since we implemented the Bonferroni correction to avoid
statistical error due to multiple comparison.
Significant results were detected for the tasks RAVLT, CPT-IP, DSST, SVF, TMTB and
both subtests of the WAIS (see Table 8 ). In all of these tasks, subjects suffering from
recent onset psychosis performed significantly worse than their counterparts from the
recent onset depression group. Hence, our findings suggest that patients in the early
stage of psychosis exhibit greater deficits in the cognitive domains speed of processing,
attention, verbal learning, executive functions and the estimate measures for premorbid
IQ than patients that battle with their first depressive episode. In contrast, for the do-
mains working memory, visual learning and social cognition, no statistically significant
performance differences could be found.
The second aim of my study was to generate classification models with a support vec-
tor machine that differentiate between ROD and ROP subjects based on group-specific
patterns in the neurocognitive data. Consequently, two analyses were conducted: the
ROD vs. ROP - 23 variables Analysis which aims to identify said patterns within 23
neurocognitive features that are typically highlighted in univariate neuropsychological
analyses, and the ROD vs. ROP - 214 variables Analysis that derives its information
from all 214 neurocognitive features measured throughout the neurocognitive assessment
of this study.
For the ROD vs. ROP - 23 variables Analysis, classification accuracy was set at 63.8%,
with a respective sensitivity of 70.7% and a specificity of 56.9%. The ROD vs. ROP -
214 variables Analysis on the other side, being availed with a much more comprehensive
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data set, reached a balanced accuracy of 71.6%, a sensitivity of 72.4% and a specificity of
70.7%, therefore presenting us with a considerably higher classification performance (cf.
Table 10 and 11 ).
Lastly, I intended to test the generalizability of classification models generated through
an SVM by testing a model trained with the data of 4 centers to classify the subjects
of the remaining 5th center (Leave-center-out Analysis). Accordingly, we obtained 5 dif-
ferent classification accuracies that were averaged out in order to gain an approximate
measure of generalizability for this classification method.
In average, our models, when applied to an outside test sample, reached an overall accu-
racy of 72.4% with a likewise sensitivity and specificity of 72.4% (cf. Table 14 ).
5.1.1 Group Differences and Similarities in Demographic Data
In this study I examined a total of 116 subjects divided into two study groups. In total,
43% of the study participants were female. Each study group consisted of exactly 58 par-
ticipants. However, study groups were not matched for sex, resulting in 27.6% (n= 16)
of female subjects in the ROP group and a majority of 58.6% females in the ROD group.
Concerning the age distribution, no significant differences between the two cohorts could
be detected with a mean age of 25.5± 6.0 years in the ROD and 25.6± 5.2 years in the
ROP group. This is somewhat surprising considering the typical age-of-onset of mood
disorders being at the age of 30 (cf. [Kessler et al., 2005]) and therefore slightly later than
non-affective psychosis [Kessler et al., 2007]. However, this may be partly explained by
the strict inclusion criteria, only considering participants between the age of 15 to 40 and
therefore eliding depressive patients that experienced their age-of-onset at the far end of
the age distribution.
Regarding the psychometric instrument BDI, it is remarkable that patients with recent
onset psychosis score almost just as high on depressive symptoms as patients with recent
onset depression (24.6 ± 12.3 points vs. 25.7 ± 13.1 points, respectively). One possible
explanation for this is the occurrence of negative symptoms such as loss of interest and
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anhedonia in psychotic disorders that can reach a severity primarily observed in MDD
[Velligan and Alphs, 2008, Andreasen, 1982].
However, this approach stands in contradiction with the fact that ROP subjects in this
study scored lower on the PANSS negative subscale than schizophrenic patients in previ-
ous research [Kay et al., 1987], suggesting that in first episode psychosis, negative symp-
toms are less prominent or distinct than the positive and general symptomatology.
Eventually, this leaves us with two possible explanations: either there is a significant
discrepancy between how subjects from the ROP group rate their symptoms themselves
(BDI) and how the interviewer evaluates the negative symptoms of the subject (PANSS),
or ROP subjects in our collective are generally more severely diseased than subjects from
the ROD group.
The latter of these two explanations is additionally supported by the observation that
ROP subjects score significantly lower on both versions, symptoms and impairment/
disability, of the Global Assessment of Functioning, when compared to ROD subjects
(cf. Table 5 ). However, whether this theorized imbalance of illness severity between the
ROD and ROP groups really exists, or whether this is a random constellation condi-
tioned by relatively small sample sizes remains the focus of further investigation within
the PRONIA study.
5.1.2 Performance Differences in the Neuropsychological Test Battery
As introduced in the chapters 2.3.1 and 2.3.2, both, major depressive as well as psy-
chotic disorders exhibit diverse cognitive impairments, even from an early stage on
[Lee et al., 2012, Mesholam-Gately et al., 2009]. Furthermore, the two disease spectra
show certain similarities regarding the cognitive domains affected, with overlaps existing
especially in the domains executive functioning, (working) memory, attention and pro-
cessing speed.
In this study, I examine whether it is possible to reveal significant performance differ-
ences between ROD and ROP subjects, even in cognitive domains that are associated
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with general impairments in both entities.
When focusing on the mean scores in the results, it quickly becomes apparent that sub-
jects from the ROP group scored lower in almost every neurocognitive task examined (cf.
Table 8 ). These differences in the mean scores where statistically significant for 9 out
of 23 variables, therefore indicating significant performance differences in the cognitive
domains speed of processing, attention, verbal learning, executive functions and premor-
bid IQ. Hence, ROP subjects also presented greater impairments in domains that have
been proven to be generally impaired in depressive disorders as well (speed of processing,
attention,executive functions, cf. [McIntyre et al., 2013] and [Lee et al., 2012]).
These findings are well in line with previous studies investigating similar questions. For
instance, regarding the CPT-IP covering the domain attention, researchers have found
deficits within psychotic patients to be much more comprehensive in comparison to de-
pressive patients [Cornblatt et al., 1989, Nelson et al., 1998]. Further studies examin-
ing cognitive performance differences between psychotic depression and non-psychotic
depression found patients with psychotic symptoms to perform generally worse, with
cognitive impairments in psychotic depression resembling more the findings observed
in schizophrenia than those in non-psychotic depression [Basso and Bornstein, 1999],
[Schatzberg et al., 2000], [Jeste et al., 1996].
Another quite impressive result is the performance difference concerning the premor-
bid IQ. Here, on both our subscales, ROP subjects score significantly lower with re-
sults being up to one standard deviation below the ROD group’s result. These results
are supported by prior findings of decreased premorbid IQ in schizophrenic patients
[Woodberry et al., 2008].
It must be taken into consideration that all results of the performance comparisons need
to be critically examined, since in our study the study groups were not matched for sex
nor was the data corrected for confounding variables such as years of education. Never-
theless, we find numerous disparities in the performance of ROD and ROP subjects that
are concordant with previous research and the prevailing psychiatric doctrine.
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5.1.3 The ROD vs. ROP -23 and -214 variables Analyses
To the best of my knowledge, this is the first study aiming to generate classification mod-
els to differentiate between recent onset depression and recent onset psychosis relying
solely on neurocognitive data. However, previous studies have already shown that A) it
is possible to differentiate between schizophrenia and mood disorders based on patterns in
structural MRI data [Koutsouleris et al., 2015] and B) neurocognitive data bears valuable
information that -when investigated in a multivariate machine learning environment- can
facilitate the identification of ARMS subjects and furthermore even predict their further
outcome [Koutsouleris et al., 2011].
To study the performance of neurocognitive pattern recognition models in the differenti-
ation of psychotic and major depressive disorder, I performed two different analyses: The
ROD vs. ROP -23 variables Analysis and the ROD vs. ROP -214 variables Analysis.
Both approaches produced significant results with classification accuracies of 63.8% and
71.6%, thereby suggesting that pattern recognition models based on neuropsychological
data hold a considerable diagnostic power that may facilitate diagnostic differentiation
when applied to new unseen patients.
Interestingly, in this study the classification accuracy increases when the SVM is pro-
vided with greater, more comprehensive sets of variables: although the ROD vs. ROP
-23 variables Analysis is provided with features that have already proven to hold signif-
icant information for the differentiation of ROD vs. ROP in the univariate statistical
approach, the SVM reaches higher classification accuracies when provided with more
variables. This finding underlines the importance of vast and comprehensive data sets in
the framework of multivariate machine learning analysis.
Besides the mere classification accuracy, the two analyses also differed regarding the most
decisive features for label assignment. Accordingly, in the ROD vs. ROP -23 variables
Analysis, the most decisive features (cf. Table 10 ) mainly covered the cognitive domains
speed of processing, premorbid IQ, visual and verbal learning. In previous research, es-
pecially the domains speed of processing, premorbid IQ and verbal learning have been
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found to be significantly impaired in patients with psychotic disorders and therefore it
is of no surprise that performance in these domains had a driving effect for classification
[Heinrichs and Zakzanis, 1998, Mesholam-Gately et al., 2009, Reichenberg et al., 2008].
In the ROD vs. ROP -214 variables Analysis, features that had the greatest decision
weights for classification mainly belonged to the cognitive domains working memory, pre-
morbid IQ, attention, speed of processing, thus presenting a slightly different composition.
Interestingly, for neither of the two approaches did the domains executive functions and
social cognition show a notable decisive value for label assignment. This is somewhat
surprising since in previous research deficits in executive functions and social cogni-
tion have been described as core features of cognitive impairment in psychotic patients
[Lencz et al., 2006, Reichenberg et al., 2008, Green and Horan, 2010].
However, it must be kept in mind that the distribution of decision weights in multivariate
analyses is a highly relative calculation whose results have to be handled with caution and
may not allow direct conclusions. Besides, the PRONIA Neuropsychological Test Battery
was originally assembled with the intention of detecting neurocognitive impairment in a
broad spectrum of domains. Reversely, this means that our results may not always be
comparable to those of studies extensively examining impairments in only one specific
cognitive domain.
Nevertheless, the presumption that pattern recognition methods may identify new and
different patterns of illness-specific impairments (than those detected using univariate
statistical methods) is an exciting outlook that deserves and requires extensive further
investigation.
5.1.4 Leave-Center-Out Analysis and Generalizability
The Leave-center-out Analysis was conducted in order to test the SVM classifiers for
their generalizability. We wanted to examine whether the patterns of neurocognitive
performance the SVM identified for both study groups actually apply to depressive and
psychotic patients in general. In this context, generalizability is synonymous with the
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external validity, since in this study subjects from the various centers were recruited in
different countries and tested in different languages.
In detail, the idea of the Leave-center-out Analysis was that if classifiers, that were trained
on data from 4 different centers and that are tested on the remaining 5th center, reach
similar classification accuracies as in the ROD vs. ROP -23 and -214 variables analyses,
it can be concluded that the patterns based on which classification is conducted are ac-
tually illness-specific and do not randomly occur in the study demographic at hand.
Furthermore, we performed this Leave-center-out Analysis for each center as testing data,
thereby gathering additional information regarding the heterogeneity between the data
of the centers.
Accordingly, the mean classification accuracy of the Leave-Center-Out Analysis was
72.4% with a sensitivity and a specificity of likewise 72.4%, whereas the accuracies for
each center individually ranged between 59.1 and 82.1%. These results, even on the lower
end, are well above a random classification accuracy and therefore give reason to believe
that our models are generalizable to a certain extend. Moreover, the mean accuracy of
72.4% is well in line with the results of the ROD vs. ROP -214 variables analysis (bal-
anced accuracy: 71.6%).
However, the variety of accuracies between the different centers as test data remains
rather conspicuous. These differences could be explained by an overfitting of the clas-
sification models, but also by other confounding variables like differences in recruiting
and testing between the centers. Additionally, it has to be remembered that the subject
cohorts of the 5 different centers have not been matched for age, sex or total number
of subjects. Accordingly, the LMU study group consists of 41 subjects in total, whereas
there are only 8 subjects in the Uni BHAM cohort (3 ROD, 5 ROP, cf. Table 3 ). Thus,
when conducting an analysis that trains on the 108 subjects of the other 4 centers and
tests its classification accuracy on the 8 subjects from Uni BHAM, a single misclassifica-
tion will already lead to a decrease of 12.5% in balanced accuracy.
In conclusion, the results of the leave-center-out approach suggest that patterns of per-
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formance and impairment in the neuropsychological assessment identified in recent onset
depressive and recent onset psychotic patients do well generalize to outside subjects.
Therefore, it is unlikely that these patterns are based on a statistical error or a strong
overfitting effect of the SVM. However, to further evaluate the generalizability of neu-
rocognitive patterns in the early stages of mental disorders it will be essential to test
on larger study cohorts that have been matched to the training data for confounding
variables such as sex, age and years of education.
5.2 Conclusions and Limitations
In a first step, we were able to identify statistically significant performance differences
between ROD and ROP subjects on the PRONIA Neuropsychological Test Battery by
conducting 2-sample t-tests. ROP participants scored poorer than ROD patients in al-
most every task. Significant differences were found in 9 out of 23 neurocognitive variables,
covering all cognitive domains except executive functions and social cognition. Therefore,
we can conclude that patients in the early stage of psychosis present greater and more
profound cognitive deficits than people suffering from recent onset depression. However,
the cognitive data examined in these analyses was not corrected for age, sex, years of
education or symptom/illness severity. Therefore, it will be necessary to replicate these
results with a greater data set, that has been standardized with the data of a compre-
hensive cohort of healthy controls. Furthermore, it would be of interest to compare the
two study groups to a matched cohort of HCs in terms of performance differences.
Secondly, the results of the ROD vs. ROP analyses with 23 and 214 variables suggest
that it is possible to identify patterns in the performance on neurocognitive assessments
that are specific in depression and psychotic disorders and that further allow differential
diagnosis with a considerable diagnostic accuracy. That being said, we further conclude
that this differentiation gains diagnostic power with greater numbers of clinical variables
that allow the SVM to recognize specific patterns within.
What is more, the machine learning algorithms seem to identify alternating patterns of
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disease specific cognitive impairments to those that have been identified by conducting
univariate statistics in previous studies. However, it is indispensable to reevaluate this
finding by examining greater study samples with data that has been thoroughly con-
trolled and standardized in order to avoid errors due to confounding variables.
Lastly, results of the Leave-center-out Analysis confirm our assumption that neurocogni-
tive data holds valuable information for the diagnostic differentiation of early stages of
psychosis and depression. With an overall accuracy of over 72%, our classification models
in this analysis have proven to be generalizable to subjects from outside centers that have
been recruited and tested by different clinicians, in a different environment and partly
even in a different language and country. The results of this analysis are merely aﬄicted
by the considerable differences in the sample sizes of the study centers. Due to the fact
that this study had only access to a preliminary data set of the PRONIA study, this
limitation could not be cleared at the time of analysis.
The results of this study give evidence to the assumption that neurocognitive data holds
valuable information for differential diagnosis in psychiatry. As discussed above, these
results will have to be validated by replication in the further process and evaluation of
the PRONIA study.
5.2.1 Future Prospects
Besides the replication of the results of this study with larger and standardized data sets,
it will be of great interest to examine the value of neurocognitive data in the framework of
a multimodal multivariate approach. In previous studies, structural and functional brain
imaging has proven its potential to enable accurate differential diagnosis when included
and analyzed by pattern recognition algorithms like the SVM [Kambeitz et al., 2015,
Kambeitz et al., 2016, Kambeitz et al., 2014]. In the future, the classification accuracy
of machine learning algorithms could possibly be improved when provided with data of
additional modalities such as psychometric instruments, biographic data, genetic data,
blood results or -as examined in this study- neurocognitive performance.
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Another promising application of pattern recognition algorithms concerns the domains
early disease recognition and prediction. Recently, several studies have been published
that do not only investigate multivariate pattern analysis in order to identify illness-
specific alterations in diverse data modalities, but that also aim to establish classifica-
tion models that allow accurate prediction concerning functional outcomes and transition
probabilities from clinical high risk for psychosis to frank psychosis [Koutsouleris et al., 2009,
Koutsouleris et al., 2011, Koutsouleris et al., 2014]. In this context, the introduction of
multimodal classifiers constitutes an interesting and promising approach that may sub-
sequently enhance diagnostic accuracy as well as patient outcome in clinical psychiatry
in the future.
71
6 Acknowledgments
First and foremost I would like to thank Prof. Dr.med. Nikolaos Koutsouleris for in-
troducing me into his team and the world of psychiatric research and giving me the
opportunity, knowledge and resources to accomplish this work.
I am particularly grateful to Dr.med. Sebastian von Saldern who never grew tired of
encouraging me, teaching me and guiding me along my way. Further, I would like to
extend my thanks to Dr. Lana Kambeitz-Ilankovic and Dr.med. Joseph Kambeitz for
their valuable insights and their kind hearts.
My grateful thanks are especially extended to Johanna Weiske who never grew tired of
listening to my sorrows and complains and who always offered a helping hand.
Also I would like to thank my wonderful colleagues and former co-workers in the PRONIA
group Maria Fernanda Urquijo, Dr. Dominic Dwyer, Shalaila Haas, Rachele Sanfelici and
Carlos Cabral. I could not have done this work without your help.
Lastly, I want to express my eternal gratefulness to my parents, Ina and Michael, for
always providing me with their love, wisdom, experience and kindness.
72
7 Appendix
7.1 List of neurological and somatic diseases leading to study
exclusion
 Somatic diseases:
– Hypertension (Grade II or higher)
– Sarcoidosis (Boeck’s disease)
– Inflammatory vascular diseases
* Systemic vasculitis
* Polyarteritis nodosa
* Giant-cell arteritis
– Hepatic cirrhosis
– Encephalopathy
* Pancreatic encephalopathy
* Wernicke’s disease
– Endocrinological diseases
* Known History of Diabetes mellitus
* Hyperthyroidism
* Hypothyroidism; if untreated
* Addison’s disease
* Cushing’s syndrome
– Hematologic disease
* Leucaemia (all forms)
* Polycythemia vera
– Immunological diseases
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* Systemic lupus erythematosus
– Cancer
 Neurological diseases:
– Intrauterinely and perinatally acquired brain damages
* Little’s disease
* Morbus haemolyticus neonatorum (Fetopathia serologica, Erythroblasto-
sis fetalis)
* Congenital rubella syndrome
* Congenital toxoplasmosis
* other congenital embryopathia (Lues, CMV, HIV, Mumps)
* Fetal alcohol spectrum disorder
– Malformations of the brain
* Micro-/Macrocephaly
* (Meningo-)encephalocele
* Hydrocephalus
* Neurofribromatosis
* Tuberous sclerosis
* Encephalotrigeminal angiomatosis
* Von Hippel-Lindau disease
– Intracranial tumors
* Medulloblastoma
* Astrocytoma
* Oligodendroglioma
* Glioblastoma
* Vestibular schwannoma
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* Meningioma
* (Pituitary) adenoma
* Cerebral metastasis
– Dementia
* Alzheimer’s disease
* Frontotemporal dementia
* Dementia with Lewy bodies
– Dystonia
– Tourette syndrome
– Metabolic diseases
* Lipoidosis
· Leukodystrophy
· Tay-Sachs disease
· Refsum disease
· Niemann-Pick disease
· Gaucher’s disease
* Phenylketonuria
* Maple syrup urine disease
* Hartnup disease
* Galactosemia
* Wilson’s disease
– Inflammatory neurological diseases
* Multiple sclerosis (encephalomyelitis disseminata)
* Meningitis
* Encephalitis
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* Neurosyphilis
* HIV-encephalitis
* Behcet’s disease
– Parkinson’s disease
– Huntington’s disease
– Epilepsy
– Autism
– Traumatically acquired brain damage
– Stroke
– Migraines with reoccurring episodes/symptoms within the last 3 months
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7.2 List of variables for the ROD vs ROP - 214 Analysis
RAVLT:
Immediate 1 repetition list A
Immediate 2 repetition list A
Immediate 3 repetition list A
Immediate 4 repetition list A
Immediate 5 repetition list A
Immediate out of list words 1 repetition list A
Immediate out of list words 2 repetition list A
Immediate out of list words 3 repetition list A
Immediate out of list words 4 repetition list A
Immediate out of list words 5 repetition list A
Immediate repeated words 1 repetition list A
Immediate repeated words 2 repetition list A
Immediate repeated words 3 repetition list A
Immediate repeated words 4 repetition list A
Immediate repeated words 5 repetition list A
Interference Immediate repetition list B
Interference Immediate words from list A repetition list B
Interference Immediate out of list words repetition list B
Interference Immediate repeated words repetition list B
Interference Immediate 6 repetition list A
Interference Immediate out of list words 6 repetition list A
Interference Immediate repeated words 6 repetition list A
Interference Immediate words from list B 6 repetition list A
Delayed repetition list A
Delayed repetition out of list words list A
Delayed repetition repeated words list A
Delayed repetition words from list B list A
FDS/BDS:
BDS Number of correct trials
BDS Maximum digits string length correctly reminded at least once
FDS Number of correct trials
FDS Maximum digits string length correctly reminded at least once
DANVA:
Raw Score correct
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CPT-IP:
Number correct 50 trials
Number error distracting stimuli 50 trials
Number error filler stimuli 50 trials
Number omissions 50 trials
Number correct 100 trials
Number error distracting stimuli 100 trials
Number error filler stimuli 100 trials
Number omissions 100 trials
Number correct 150 trials
Number error distracting stimuli 150 trials
Number error filler stimuli 150 trials
Number omissions 150 trials
Number correct 200 trials
Number error distracting stimuli 200 trials
Number error filler stimuli 200 trials
Number omissions 200 trials
Number correct 250 trials
Number error distracting stimuli 250 trials
Number error filler stimuli 250 trials
Number omissions 250 trials
Number correct 300 trials
Number error distracting stimuli 300 trials
Number error filler stimuli 300 trials
Number omissions 300 trials
Number correct whole test
Number error distracting stimuli whole test
Number error filler stimuli whole test
Number omissions whole test
Reaction times correct whole test
Reaction times error distracting whole test
Reaction times error filler whole test
Reaction times correct 50 trials
Reaction times correct 100 trials
Reaction times correct 150 trials
Reaction times correct 200 trials
Reaction times correct 250 trials
Reaction times correct 300 trials
Reaction times error distracting 50 trials
Reaction times error distracting 100 trials
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DSST:
Correct number symbol matchings
Error number symbol matchings
Raw score correct
PVF:
PVF Correct 00 60 letter 1
PVF Correct 00 15 letter 1
PVF Correct 15 30 letter 1
PVF Correct 30 45 letter 1
PVF Correct 45 60 letter 1
PVF Error 00 60 letter 1
PVF Error 00 15 letter 1
PVF Error 15 30 letter 1
PVF Error 30 45 letter 1
PVF Error 45 60 letter 1
PVF Repetition 00 60 letter 1
PVF Repetition 00 15 letter 1
PVF Repetition 15 30 letter 1
PVF Repetition 30 45 letter 1
PVF Repetition 45 60 letter 1
SVF:
SVF Correct 00 60 category 1
SVF Correct 00 15 category 1
SVF Correct 15 30 category 1
SVF Correct 30 45 category 1
SVF Correct 45 60 category 1
SVF Error 00 60 category 1
SVF Error 00 15 category 1
SVF Error 15 30 category 1
SVF Error 30 45 category 1
SVF Error 45 60 category 1
SVF Repetition 00 60 category 1
SVF Repetition 00 15 category 1
SVF Repetition 15 30 category 1
SVF Repetition 30 45 category 1
SVF Repetition 45 60 category 1
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SOPT:
Errors 4 elements 01
Errors 4 elements 02
Errors 4 elements 03
Perseveration Errors 4 elements 01
Perseveration Errors 4 elements 02
Perseveration Errors 4 elements 03
Maximum correct responses before error 4 elements 01
Maximum correct responses before error 4 elements 02
Maximum correct responses before error 4 elements 03
Errors 6 elements 01
Errors 6 elements 02
Errors 6 elements 03
Perseveration Errors 6 elements 01
Perseveration Errors 6 elements 02
Perseveration Errors 6 elements 03
Maximum correct responses before error 6 elements 01
Maximum correct responses before error 6 elements 02
Maximum correct responses before error 6 elements 03
Errors 8 elements 01
Errors 8 elements 02
Errors 8 elements 03
Perseveration Errors 8 elements 01
Perseveration Errors 8 elements 02
Perseveration Errors 8 elements 03
Maximum correct responses before error 8 elements 01
Maximum correct responses before error 8 elements 02
Maximum correct responses before error 8 elements 03
Errors 10 elements 01
Errors 10 elements 02
Errors 10 elements 03
Perseveration Errors 10 elements 01
Perseveration Errors 10 elements 02
Perseveration Errors 10 elements 03
Maximum correct responses before error 10 elements 01
Maximum correct responses before error 10 elements 02
Maximum correct responses before error 10 elements 03
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ROCF - Copy:
Score element 01
Score element 02
Score element 03
Score element 04
Score element 05
Score element 06
Score element 07
Score element 08
Score element 09
Score element 10
Score element 11
Score element 12
Score element 13
Score element 14
Score element 15
Score element 16
Score element 17
Score element 18
ROCF - Immediate:
Score element 01 Immediate
Score element 02 Immediate
Score element 03 Immediate
Score element 04 Immediate
Score element 05 Immediate
Score element 06 Immediate
Score element 07 Immediate
Score element 08 Immediate
Score element 09 Immediate
Score element 10 Immediate
Score element 11 Immediate
Score element 12 Immediate
Score element 13 Immediate
Score element 14 Immediate
Score element 15 Immediate
Score element 16 Immediate
Score element 17 Immediate
Score element 18 Immediate
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ROCF - Delayed:
Score element 01 Delayed
Score element 02 Delayed
Score element 03 Delayed
Score element 04 Delayed
Score element 05 Delayed
Score element 06 Delayed
Score element 07 Delayed
Score element 08 Delayed
Score element 09 Delayed
Score element 10 Delayed
Score element 11 Delayed
Score element 12 Delayed
Score element 13 Delayed
Score element 14 Delayed
Score element 15 Delayed
Score element 16 Delayed
Score element 17 Delayed
Score element 18 Delayed
ROCF - Whole:
Accuracy whole
Accuracy whole Immediate
Accuracy whole Delayed
Placement whole
Placement whole Immediate
Placement whole Delayed
Score whole
Score whole Immediate
Score whole Delayed
Time Copy
Time Immediate
Time Delayed
TMTA:
TMTA Time of completion
TMTA Errors
TMTA Violations
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TMTB:
TMTB Time of completion
TMTB Errors
TMTB Violations
WAIS:
WAIS V Standard score
WAIS MR Standard score
7.3 List of Abbreviations
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 DGPPN - Deutsche Gesellschaft fu¨r Psychiatrie und Psychotherapie, Psychoso-
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 DSM-5 - Diagnostic and Statistical Manual of Mental Disorders
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 MDD - Major Depressive Disorder
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 SAT - Salience Attribution Test
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 SVM - Support Vector Machine
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